POPULARITY
Categories
351 episodes with american colleges
223 episodes with american colleges
133 episodes with american colleges
102 episodes with american colleges
149 episodes with american colleges
85 episodes with american colleges
38 episodes with american colleges
117 episodes with american colleges
38 episodes with american colleges
75 episodes with american colleges
41 episodes with american colleges
44 episodes with american colleges
37 episodes with american colleges
43 episodes with american colleges
40 episodes with american colleges
42 episodes with american colleges
77 episodes with american colleges
16 episodes with american colleges
37 episodes with american colleges
32 episodes with american colleges
39 episodes with american colleges
36 episodes with american colleges
19 episodes with american colleges
23 episodes with american colleges
39 episodes with american colleges
32 episodes with american colleges
21 episodes with american colleges
22 episodes with american colleges
31 episodes with american colleges
26 episodes with american colleges
28 episodes with american colleges
30 episodes with american colleges
23 episodes with american colleges
26 episodes with american colleges
15 episodes with american colleges
17 episodes with american colleges
20 episodes with american colleges
22 episodes with american colleges
24 episodes with american colleges
11 episodes with american colleges
24 episodes with american colleges
23 episodes with american colleges
16 episodes with american colleges
22 episodes with american colleges
23 episodes with american colleges
11 episodes with american colleges
23 episodes with american colleges
29 episodes with american colleges
29 episodes with american colleges
20 episodes with american colleges
21 episodes with american colleges
14 episodes with american colleges
15 episodes with american colleges
23 episodes with american colleges
HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
In this episode, we review key updates from the 2026 ACC-AHA Guidelines on the Management of Dyslipidemia. Key Concepts The PREVENT ASCVD equation is now recommended to calculate ASCVD risk, with thresholds at 3%, 5%, and 10%. The previous 7.5% threshold for statin treatment is now 5%. In addition to the 10-year ASCVD estimate, clinicians should consider the use of Lp(a), "risk enhancers", and coronary artery calcium (CAC) scans as a "tie breaker" with shared decision-making when the decision to treat is not clear. In addition to LDL goals of < 100, < 70, or < 55 (depending on risk), the new guidelines also suggest non-HDL-C and apoB goals once LDL cholesterol is at goal. Many patients will require non-statin therapies to achieve lipid goals. The recommended non-statin therapies include ezetimibe, PCSK9 mAb, PCSK9-interfering RNA, and bempedoic acid. References Writing Committee Members, Blumenthal RS, Morris PB, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026;153(17):e1154-e1276. doi:10.1161/CIR.0000000000001423 Wiggins BS, Barac A, Benziger CP, et al. 2026 Dyslipidemia Guideline-at-a-Glance. J Am Coll Cardiol. 2026;87(19):2617-2623. doi:10.1016/j.jacc.2026.02.4872 Superko H, Garrett B. Small Dense LDL: Scientific Background, Clinical Relevance, and Recent Evidence Still a Risk Even with 'Normal' LDL-C Levels. Biomedicines. 2022;10(4):829. Published 2022 Apr 1. doi:10.3390/biomedicines10040829
Graduation season is once more upon us. The long school year has come to a close, and now, in caps and gowns, the nation's graduates gather to receive their various certifications, diplomas, and degrees, and listen to wisdom from a speaker. However, many college graduations are not the same tranquil affairs they used to be. FIRE, the Foundation for Individual Rights and Expression, reports that attempts by students to disinvite commencement speakers over political beliefs have increased sharply over the last decade or so. To name one example, students at Morehouse School of Medicine are attempting to block the commencement speech of alumnus Congressman Rich McCormick, over his stances against DEI, abortion, and transgender surgeries among other views. Some schools, such as New York University, have switched to recorded remarks by students in lieu of an in-person speaker. At this point, the level of intolerance and intellectual coddling taking place at American universities is not a new story. It's bad, but is there a way back? This week, the Heritage Foundation is releasing a new book: Higher Education in America: It's Worse than you Think. I sat down with Jonathan Butcher, Acting Director of Heritage's Center for Education Policy and one of the book's authors, to ask whether he believes there is hope for the American university. --- Email us with thoughts, questions, or suggestions: HeritageExplains@heritage.org ---Jonathan Butcher on X: https://x.com/JM_Butcher?lang=enHigher Education in America: It's Worse Than You Think: https://a.co/d/0aMuIWzN
Click to Text Thoughts on Today's EpisodeDoes your sleep tracker know you better than you know yourself — or is it just stressing you out? If you've ever woken up more anxious about your sleep score than actually rested, this episode is for you. We're cutting through the noise, the supplements, and the sleep-maxing culture to get back to what actually works — a common-sense, no-fuss approach to sleeping better in midlife. Because you're not broken. You're just navigating a body that's changing, and there's a lot you can do about it.In this episode we cover:Why your sleep target might not actually be 8 hours — and what the research really saysMorning light exposure and why it's one of the most powerful (and free) sleep tools availableThe concept of "orthosomnia" — sleep anxiety caused by your wearable data — and when to just take it offHow the narrative in your head affects your sleep (and a simple CBT-I reframe to try tonight)Caffeine's half-life and why that afternoon coffee may still be in your system at midnightAlcohol's impact on REM sleep and a simple habit to reduce the damageBlood sugar balance and how overnight crashes could be waking you up at 3 AMMagnesium — what the research supports, which forms to look for, and how to get more through foodBlue light, screens, and practical ways to protect your melatonin production at nightPre-sleep nutrition: why going to bed hungry is just as disruptive as eating a heavy mealHormone therapy as a legitimate sleep tool — and why it's worth a conversation with your doctorBreathing techniques (4-7-8 and box breathing) for falling back asleep in the middle of the nightThe eye movement trick that works for falling back asleepTemperature regulation and the ideal bedroom temp for quality sleepConsistent sleep and wake schedules — and why weekends matter more than you thinkExercise timing and why a late intense workout might be costing you sleepThe truth about melatonin dosing — why less is almost always moreCBT-I as a first-line clinical recommendation and the free app that can help you implement itSource Links1. Seven hours optimal in midlife Cambridge/Fudan University study, Nature Aging (2022): https://www.cam.ac.uk/research/news/seven-hours-of-sleep-is-optimal-in-middle-and-old-age-say-researchersAASM/Sleep Research Society joint consensus (seven or more hours): https://aasm.org/seven-or-more-hours-of-sleep-per-night-a-health-necessity-for-adults/2. Morning light / suprachiasmatic nucleus Frontiers in Neural Circuits (2024) — SCN as master circadian pacemaker: https://www.frontiersin.org/journals/neural-circuits/articles/10.3389/fncir.2024.1385908/full3. Magnesium L-threonate for sleep 2024 randomized controlled trial, Sleep Medicine X (ScienceDirect): https://www.sciencedirect.com/science/article/pii/S25901427240001934. Melatonin dosing Sleep Foundation — melatonin dosage guide (reviewed by board-certified sleep physician): https://www.sleepfoundation.org/melatonin/melatonin-dosage-how-much-should-you-takeMelatonin content variability in supplements (the 83–478% finding): https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053496/5. CBT-i as first-line treatment American College of Physicians recommendation: https://www.acponline.org/acp-newsroom/acp-recommends-cognitive-behavioral-therapy-as-initial-treatment-for-chronic-insomnia6. The Atlantic article "American Insomnia" by Jennifer Senior, The Atlantic, August 2025: https://www.theatlantic.com — search "American Insomnia Jennifer Senior" (may be behind paywall; Apple News+ has audio version)My latest recommended ways to nourish and move your body, mind and spirit: Nourished Notes Bi-Weekly Newsletter30+ Non-Gym Ways to Improve Your Health (free download)Connect with Amy: GracedHealth.com Instagram: @GracedHealthYouTube: @AmyConnell
Learn how modern single-family offices are structured, including classic and profits interest models, tax efficiency, governance, and investment management. The American College of Trust and Estate Counsel, ACTEC, is a professional society of peer-elected trust and estate lawyers in the United States and around the globe. This series offers professionals best practice advice, insights, and commentary on subjects that affect the profession and clients. Learn more in this podcast.
Contributor: Aaron Lessen, MD Educational Pearls: Back pain is a common presenting complaint in the emergency department. Challenges arise when tailoring care to elderly populations using standard medical therapy: Muscle relaxants carry the risk of CNS depression or anticholinergic effects such as urinary retention and confusion. Pain medications such as opiates have side effects including constipation, respiratory depression, and hypotension. NSAIDs carry a risk of GI bleeding and worsening kidney function with chronic use. A randomized clinical trial assessing the effects of acupuncture on low back pain took 800 adults aged 65 and older with chronic low back pain and placed them into one of three treatment arms: Usual medical care Standard acupuncture consisting of 8–15 treatment sessions over 12 weeks, plus usual medical care Standard acupuncture consisting of 8–15 treatment sessions over 12 weeks, plus 4-6 maintenance sessions during the next 12 weeks, plus usual medical care Using the Roland-Morris Disability Questionnaire (RMDQ) score, they assessed disability at 6 months and 12 months. The study found that those who had undergone treatment with acupuncture had significantly greater improvements in disability related to low back pain compared to the group that was only treated with usual medical care. Acupuncture is not used in the ER, but could represent a relatively safe adjunctive therapy for patients who are not responding to standard medical therapy alone. References: American College of Surgeons Committee on Trauma. Best practices guidelines: geriatric trauma management. American College of Surgeons; 2023. Accessed May 27, 2026. https://www.facs.org/media/ubyj2ubl/best-practices-guidelines-geriatric-trauma.pdf DeBar LL, Wellman RD, Justice M, et al. Acupuncture for chronic low back pain in older adults: a randomized clinical trial. JAMA Netw Open. 2025;8(9):e2531348. doi:10.1001/jamanetworkopen.2025.31348 Summarized by Ashley Lyons, OMS3 | Edited by Ashley Lyons & Ahmed Abdel-Hafiz, NREMT-P
Dr. Centor discusses the American College of Physicians' recommendations for respiratory syncytial virus vaccination with Dr. Rachael Lee.
If you've been told you have high LDL cholesterol in your blood, the first place to begin to try to improve it is with diet and exercise. That's according to new guidelines from the American College of Cardiology, and such … The first strategy to improve blood cholesterol levels in lifestyle management, Elizabeth Tracey reports Read More »
When it comes to ideal LDL cholesterol levels in the blood, ideal is a bit of a moving target. Johns Hopkins cardiologist Roger Blumenthal, chair of an American College of Cardiology committee that has just updated cholesterol guidelines, says it … What LDL cholesterol level should you be aiming for? Elizabeth Tracey reports Read More »
Management of blood cholesterol is a major factor in the prevention of cardiovascular disease, as reflected in new guidelines released by the American College of Cardiology, and it should start early in life and be monitored throughout the lifespan. Johns … Monitoring cholesterol and other factors should be done regularly to prevent cardiovascular disease, Elizabeth Tracey reports Read More »
A quarter of US adults have elevated levels of LDL, the type of cholesterol in the blood most often associated with atherosclerosis and cardiovascular disease. Now the American College of Cardiology has issued new guidelines for managing cholesterol, last updated … New guidelines from the American College of Cardiology for cholesterol guidelines are here, Elizabeth Tracey reports Read More »
In this episode of the Neuroveda Podcast for Complex Health, Gillian Ehrlich sits down with returning guest Dr. Dawn Ibsen, compounding pharmacist and passionate advocate for personalized medicine. Together they unpack the science, history, and growing interest around methylene blue — from its origins as a treatment for malaria to its modern use in brain health, mitochondrial support, longevity, and biohacking.They also dive into the rapidly changing world of compounding pharmacies, including concerns surrounding compounded thyroid medications, the evolving landscape of peptide access, and the balance between innovation, safety, and patient care. This conversation explores what happens when cutting-edge medicine meets regulation and why personalized treatment still matters.Topics include:• Methylene blue safety, dosing, and mechanisms• Mitochondrial health and energy production• Compounding pharmacy quality and patient advocacy• Thyroid medication changes• Peptide regulation and current challenges• The future of personalized medicineBio: Dr. Dawn Ipsen, PharmD, FAPC, FACVP, FACA is a compounding pharmacist with more than 25-years of experience serving human and veterinary patients. She is the owner of two community-based compounding pharmacies in Washington state and is recognized for her expertise in personalized medication therapy, quality compounding practices, and patient-centered care.Dr. Ipsen holds an APC Fellowship and is also a Fellow of the American College of Veterinary Pharmacists and American College of Apothecaries, reflecting her advanced training and leadership in both human and veterinary compounding. In addition, she is a clinical instructor for the University of Washington School of Pharmacy and an affiliate faculty member for Bastyr University. Her professional focus includes women's health, hormone therapy, low-dose naltrexone, dermatology compounding, and complex veterinary medication solutions for small animals, exotic pets, and large animal patients.Dr. Ipsen is deeply engaged in pharmacy advocacy, education, and legislative efforts to protect patient access to compounded medications. She currently holds an APC Board of Directors position and is the founding chair for the WA State Pharmacy Association (WSPA) - Compounding Special Interest Group. The WSPA awarded her with the Distinguished Leadership Award in 2023 and the UW School of Pharmacy Distinguished Alumni Award in 2021. Dr. Ipsen regularly collaborates with prescribers, healthcare professionals, and educators to improve the therapeutic outcomes, health, education and vitality of the communities we serve.
A Conversation in Veterinary Pathology - The A.C.V.P. Podcast
In this episode, we are joined by Dr. Francisco Uzal, an internationally recognized veterinary pathologist and a global leader in pathology education. He is a professor in Pathology, Microbiology, and Immunology at the University of California, Davis, and Branch Chief at the California Animal Health and Food Safety Diagnostic Lab. Dr. Uzal has spent more than four decades in academic diagnostic pathology and is the CEO of the Davis Thompson Foundation, the world's largest organization dedicated to teaching veterinary and comparative pathology. Join us as we learn more about Dr. Uzal's career, shaped by international collaboration, mentorship, and service. He is especially known for his work in diagnostic pathology and clostridial diseases, as well as for expanding access to education. Most importantly, Dr. Uzal is a passionate educator and advocate for the global pathology community, and we're thrilled to have him with us today. So stay right here for our conversation with Dr. Francisco Uzal. ____ Links ACVP Errors in Publication Portal 2026 ACVP Annual Meeting ____ ACVP Social Media Facebook - ACVP Meetings and Topics Instagram - americancollegevetpath X (Twitter) - @ACVP LinkedIn - AMERICAN COLLEGE OF VETERINARY PATHOLOGISTS ____ Music: Guestlist by Podington Bear, licensed under an Attribution-NonCommercial 3.0 International License. The contents of this audio do not necessarily reflect the opinions of the American College of Veterinary Pathologists (ACVP) or the participants' affiliations. Spoken audio content and associated photos are the property of the American College of Veterinary Pathologists, 2026.
The American College of Obstetricians and Gynecologists (ACOG) does not recommend routine ultrasound measurement of the lower uterine segment (LUS) thickness as part of the evaluation for trial of labor after cesarean delivery (TOLAC). ACOG Practice Bulletin No. 205 (2019) on Vaginal Birth After Cesarean Delivery does not include LUS measurement among its recommendations for TOLAC candidacy assessment. The guideline focuses on clinical factors such as type of prior uterine incision, number of prior cesarean deliveries, and other obstetric history to determine TOLAC candidacy, and emphasizes that most women with one previous low-transverse cesarean delivery should be counseled about and offered TOLAC. But what if you find a likely uterine window at the LUS? Does that mandate a repeat C-section? This topic comes from Serena, one of our podcast family members. Listen in for details. 1. Dr. Chapa's Clinical Pearls, Dec 31., 2023: LUST FOR TOLAC; and follow up episode Jan 15, 20242. ACOG Practice Bulletin No. 205: Vaginal Birth After Cesarean Delivery. Committee on Practice Bulletins—Obstetrics Obstetrics and Gynecology. 2019;133(2):e110-e127. doi:10.1097/AOG.0000000000003078.3. Rozenberg P, Sénat MV, Deruelle P, et al. Evaluation of the Usefulness of Ultrasound Measurement of the Lower Uterine Segment Before Delivery of Women With a Prior Cesarean Delivery: A Randomized Trial. American Journal of Obstetrics and Gynecology. 2022. 4. Swift BE, Shah PS, Farine D. Sonographic Lower Uterine Segment Thickness After Prior Cesarean Section to Predict Uterine Rupture: A Systematic Review and Meta-Analysis. Acta Obstetricia Et Gynecologica Scandinavica. 2019. 5. McLeish SF, Murchison AB, Smith DM, et al. Predicting Uterine Rupture Risk Using Lower Uterine Segment Measurement During Pregnancy With Cesarean History: How Reliable Is It? A Review. Obstetrical & Gynecological Survey. 2023. 6. Jastrow N, Demers S, Chaillet N, et al. Lower Uterine Segment Thickness to Prevent Uterine Rupture and Adverse Perinatal Outcomes: A Multicenter Prospective study.7. American Journal of Obstetrics and Gynecology. 2016. 8. Guerby P, Bujold E, Chaillet N. Impact of Third-Trimester Measurement of Low Uterine Segment Thickness and Estimated Fetal Weight on Perinatal Morbidity in Women With Prior Cesarean Delivery. Journal of Obstetrics and Gynaecology Canada. JOGC. 2022.
Drs. McMahon and Kalunian discuss how the latest lupus nephritis guidelines from the American College of Rheumatology and European Alliance of Associations for Rheumatology are shifting care from short-term, reactive treatment to longer-term, continuous maintenance—often 3 to 5 years or more—to better prevent kidney flares and preserve renal function. They highlight emerging data on biologic-based triple therapy (including belimumab); the importance of biomarkers and repeat biopsies; and the growing push toward personalized, sometimes indefinite, therapy for high‑risk patients.
In this episode, Lillian Erdahl, MD, FACS, is joined by Pringl Miller, MD, FACS, from Physican Just Equity, and Christine Heisler, MD, FACS, from the Mayo Clinic Health System. They discuss Drs Miller and Heisler's recent article, “Whether and How Surgeons Took Action Against Workplace Microaggression: Survey of American College of Surgeons Members,” in which the authors found that the most frequent perpetrator roles were surgeon colleagues and supervisors. A total of 57.4% of surgeons took action, with informal reporting to a colleague and/or directly confronting the perpetrator being most common actions taken. Surgeons who took action were less likely to choose a career in surgery again. Disclosure Information: Drs Erdahl, Miller, and Heisler have nothing to disclose. To earn 0.25 AMA PRA Category 1 Credits™ for this episode of the JACS Operative Word Podcast, click here to register for the course and complete the evaluation. Listeners can earn CME credit for this podcast for up to 2 years after the original air date. Heisler, Christine A MD, MS, FACS; Godecker, Amy L PhD, MS; Verran, Deborah MbChB, MHSM; Sinha, Michael S MD, JD, MPH; Byam, Jerome MD; Miller, Pringl MD, FACS. Whether and How Surgeons Took Action Against Workplace Microaggression: Survey of the American College of Surgeons Members. Journal of the American College of Surgeons 242(2):p 390-400, February 2026. | DOI: 10.1097/XCS.0000000000001648 Related work: Primary Study: Heisler CA, Godecker AL, Verran D, Sinha MS, Byam J, Miller P. Workplace microaggressions: results of a survey of the American College of Surgeons members. Am J Obstet Gynecol. 2024 Aug;231(2):265.e1-265.e8. Secondary Study: Heisler CA, Godecker AL, Verran D, Sinha MS, Byam J, Miller P. Impact of Workplace Microaggressions on Surgeon Career Status and Trajectory: A Cross-Sectional Survey Study. Accepted to the Annals of Surgery Open on April 30, 2026. The secondary study was also presented at ACS Clinical Congress 2024: Heisler CA, Godecker A, Verran D, Sinha MS, Byam J, Miller P. Workplace Microaggressions and the Impact on a Surgeon's Career Trajectory: Results of a Survey of the American College of Surgeons Members. J Am Coll Surg. October 2024;239(5):S138-139. Learn more about the Journal of the American College of Surgeons, a monthly peer-reviewed journal publishing original contributions on all aspects of surgery, including scientific articles, collective reviews, experimental investigations, and more. #JACSOperativeWord
CardioNerds Dr. Joseph Kassab, Dr. Mariana Garcia-Arango, and Dr. Christopher Mason explore the technological revolution of Coronary CT Angiography (CCTA) with expert faculty Dr. Michael Gallagher. The discussion details how CCTA has evolved into a frontline diagnostic and preventive tool, moving beyond simple anatomy to incorporate physiology via CT-FFR and biology through AI-driven plaque quantification. The episode reviews landmark evidence like the SCOT-HEART and PROMISE trials, the nuances of CAD-RADS 2.0 reporting, and the emerging role of AI in monitoring treatment response and personalizing cardiovascular care. Critically, they also discuss some of the assumptions and limitations of these techniques. Stay tuned for a matching review article to be submitted to US Cardiology Review, the official Journal of CardioNerds. This episode was supported by an independent medical education grant from HeartFlow. All CardioNerds education is planned, produced, and reviewed solely by CardioNerds. Enjoy this Circulation Paths to Discovery article to learn more about the CardioNerds mission and journey. US Cardiology Review is now the official journal of CardioNerds! Submit your manuscripts here. CardioNerds Multimodality Cardiovascular Imaging PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll Pearls Shift in Paradigm: CCTA is no longer just an anatomic test; with some key limitations, it can provide anatomy, physiology (CT-FFR), and plaque biology (AI-CPA) in a single non-invasive scan. The “Power of Zero” vs. Plaque: While a normal CCTA has a >95% negative predictive value, future MIs often arise from non-obstructive plaque that traditional stress tests might miss. CAD-RADS 2.0 Utility: The addition of plaque burden modifiers (P1–P4) is a “game changer,” allowing clinicians to identify high-risk patients who need aggressive lipid-lowering despite having only mild stenosis. CT-FFR as a Virtual Stress Test: CT-FFR uses computational fluid dynamics to simulate blood flow, potentially reducing unnecessary invasive catheterizations by approximately 61% without sacrificing safety. Seeing the Invisible: AI-based quantitative plaque analysis (QCPA) can identify “subvisual” plaque and low-attenuation (lipid-rich) components that are the primary drivers of acute coronary syndromes. Show Notes How has the role of CCTA changed compared to traditional functional testing? Historically, stress testing answered “is there ischemia today?”, which often reflects late-stage disease. CCTA identifies disease across the entire spectrum, asking “is there atherosclerosis and how much plaque is present?”. Landmark evidence: SCOT-HEART showed a 41% relative risk reduction in MI at 5 years attributed to intensified preventive therapies, and PROMISE showed CCTA was better at selecting patients who truly needed invasive angiography. Diagnostic CCTA imaging depends on the protocol, contrast timing, heart rate, heart rhythm, breathholding, scanner quality, and several patient factors (obesity, prior stents, heavy calcification, complex bypass anatomy, and motion artifact all may limit imaging). “CCTA is exceptional for the right patient, with the right scanner, and the right team.” What are the key modifiers introduced in CAD-RADS 2.0, and why do they matter? CAD-RADS 2.0 moved beyond stenosis severity to include plaque burden (P0 to P4), high-risk plaque (HRP) features, and the presence of ischemia based on CT-FFR. It serves as a clinical decision support tool: a patient with mild (25-49%) stenosis but “extensive” (P4) plaque burden is considered high risk and warrants aggressive risk factor modification. How is CT-FFR calculated, and when is it most useful in clinical practice? CT-FFR uses resting CCTA data and computational fluid dynamics to create a 3D model of coronary flow during simulated maximal hyperemia. It is often used for intermediate lesions (40–90% stenosis) to predict if they are ischemia-producing, guiding the decision whether to proceed with invasive angiography. The assumptions necessary for this computational modeling may not apply well to patients with microvascular dysfunction, significant myocardial scar or prior infarction, or ventricular hypertrophy. Still, data indicate that CT-FFR performs similarly to PET in predicting hemodynamically significant lesions. CT-FFR performs well at the extremes (either clearly normal or clearly abnormal). Accuracy dips, however, in the intermediate range (~0.75-0.80), where decision-making is most critical. In this grey zone, additional factors can help guide the approach, including the amount of myocardium supplied, translesional gradient, and plaque features. CT-FFR has not been validated in distal segments, stented segments, heavily calcified coronary arteries, or in patients with severe aortic stenosis. Caution with CT-FFR should be utilized in very calcified coronary segments. What is AI-based quantitative plaque analysis (QCPA), and what metrics are ready for clinical use? This is potentially a paradigm shift, moving away from stenosis-centric thinking to a more disease burden and plaque biology focus. QCPA uses deep learning algorithms to automatically segment the vessel wall and quantify plaque volume in mm³. Ready for “prime time” metrics include: Total Plaque Volume (TPV), non-calcified plaque volume, and Low-Attenuation Plaque (LAP) burden. Can serial CCTA be used to monitor the effectiveness of medical therapies like statins? While not yet a routine guideline-driven practice, trials like PARADIGM and EVAPORATE show that therapies can stabilize plaque; notably, CCTA is better for monitoring than CAC scores, which can be misleading as statins often increase plaque calcification as part of the stabilization process. There are no randomized trials that serial CCTAs improve outcomes. Cost and radiation exposure will be notable limitations. Serial scan timing, scan acquisition and interpretation standardization would be key. Dr. Gallagher notes that we are moving toward a world in which plaque burden may become a “treatment biomarker,” similar to tumor burden in oncology. References 1. Coronary Computed Tomography Angiography From Clinical Uses to Emerging Technologies: JACC State-of-the-Art Review. Abdelrahman KM, Chen MY, Dey AK, et al. Journal of the American College of Cardiology. 2020;76(10):1226-1243. doi:10.1016/j.jacc.2020.06.076. 2. Non-Invasive Imaging in Coronary Syndromes: Recommendations of the European Association of Cardiovascular Imaging and the American Society of Echocardiography, in Collaboration With the American Society of Nuclear Cardiology, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. Edvardsen T, Asch FM, Davidson B, et al. Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography. 2022;35(4):329-354. doi:10.1016/j.echo.2021.12.012. 3. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Gulati M, Levy PD, Mukherjee D, et al. Journal of the American College of Cardiology. 2021;78(22):e187-e285. doi:10.1016/j.jacc.2021.07.053. 4. Contemporary, Non-Invasive Imaging Diagnosis of Chronic Coronary Artery Disease. van der Bijl P, Gulati M, Saraste A, et al. Lancet (London, England). 2025;406(10519):2577-2587. doi:10.1016/S0140-6736(25)01586-7. 5. State of the Art: Evaluation and Medical Management of Nonobstructive Coronary Artery Disease in Patients With Chest Pain: A Scientific Statement From the American Heart Association. Slipczuk L, Blankstein R, Bucciarelli-Ducci C, et al. Circulation. 2025;152(23):e443-e466. doi:10.1161/CIR.0000000000001394. 6. Diagnostic Performance of Fractional Flow Reserve Derived From Coronary CT Angiography: The ACCURATE-CT Study. Li C, Hu Y, Jiang J, et al. JACC. Cardiovascular Interventions. 2024;17(17):1980-1992. doi:10.1016/j.jcin.2024.06.027. 7. Clinical Outcomes Based on Coronary Computed Tomography-Derived Fractional Flow Reserve and Plaque Characterization. Sato Y, Motoyama S, Miyajima K, et al. JACC. Cardiovascular Imaging. 2024;17(3):284-297. doi:10.1016/j.jcmg.2023.07.013. 8. Clinical Use of Coronary Computed Tomography Angiography-Derived Fractional Flow Reserve: Expert Consensus by an International Working Group. Tang CX, Leipsic JA, Nørgaard BL, et al. European Radiology. 2026;:10.1007/s00330-025-12313-6. doi:10.1007/s00330-025-12313-6. 9. Diagnostic accuracy of computed tomography–derived fractional flow reserve: a systematic review. Cook CM, Petraco R, Shun-Shin MJ, et al. JAMA Cardiol. 2017;2(7):803-810. Doi:10.1001/jamacardio.2017.1314 10. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). Nørgaard BL, Leipsic J, Gaur S, et al. J Am Coll Cardiol. 2014;63(12):1145-1155. Doi:10.1016/j.jacc.2013.11.043 11. Comparison of coronary computed tomography angiography, fractional flow reserve, and perfusion imaging for ischemia diagnosis. Driessen RS, Danad I, Stuijfzand WJ, et al. J Am Coll Cardiol. 2019;73(2):161-173. Doi:10.1016/j.jacc.2018.10.056. 12. 1-year outcomes of FFRCT-guided care in patients with suspected coronary disease: the PLATFORM study. Douglas PS, De Bruyne B, Pontone G, et al. J Am Coll Cardiol. 2016;68(5):435-445. Doi:10.1016/j.jacc.2016.05.057. 13. Comparison of an initial risk-based testing strategy vs usual testing in stable symptomatic patients with suspected coronary artery disease: the PRECISE randomized clinical trial. Douglas PS, Nanna MG, Kelsey MD, et al; PRECISE Investigators. JAMA Cardiol. 2023;8(10):904-914. Doi:10.1001/jamacardio.2023.2595. 14. Diagnostic and clinical value of FFRCT in stable chest pain patients with extensive coronary calcification: the FACC study. Mickley H, Veien KT, Gerke O, et al. JACC Cardiovasc Imaging. 2022;15(6):1046-1058. doi:10.1016/j.jcmg.2021.12.010. 15. Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART). Williams MC, Kwiecinski J, Doris M, et al. Circulation. 2020;141(18):1452-1462. doi:10.1161/CIRCULATIONAHA.119.044720. 16. AI-Guided Quantitative Plaque Staging Predicts Long-Term Cardiovascular Outcomes in Patients at Risk for Atherosclerotic CVD. Nurmohamed NS, Bom MJ, Jukema RA, et al. JACC. Cardiovascular Imaging. 2024;17(3):269-280. doi:10.1016/j.jcmg.2023.05.020. 17. Interaction of AI-Enabled Quantitative Coronary Plaque Volumes on Coronary CT Angiography, FFRCT, and Clinical Outcomes: A Retrospective Analysis of the ADVANCE Registry. Dundas J, Leipsic J, Fairbairn T, et al. Circulation. Cardiovascular Imaging. 2024;17(3):e016143. doi:10.1161/CIRCIMAGING.123.016143. 18. Prognostic Value of AI-Based Quantitative Coronary CTA vs Human Reader-Based Visual Assessment: Results From the CONFIRM2 Registry. van Rosendael A, Nakanishi R, Bax JJ, et al. JACC. Cardiovascular Imaging. 2026;19(3):345-359. doi:10.1016/j.jcmg.2025.09.021.13. Pericoronary Adipose Tissue as a Marker of Cardiovascular Risk: JACC Review Topic of the Week. Tan N, Dey D, Marwick TH, Nerlekar N. Journal of the American College of Cardiology. 2023;81(9):913-923. doi:10.1016/j.jacc.2022.12.021. 19. Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients With Elevated Triglycerides on Statin Therapy: Final Results of the EVAPORATE Trial. Budoff MJ, Bhatt DL, Kinninger A, et al. European Heart Journal. 2020;41(40):3925-3932. doi:10.1093/eurheartj/ehaa652. 20. Coronary CT Angiography Evaluation With Artificial Intelligence for Individualized Medical Treatment of Atherosclerosis: A Consensus Statement From the QCI Study Group. Schulze K, Stantien AM, Williams MC, et al. Nature Reviews. Cardiology. 2026;23(2):100-115. doi:10.1038/s41569-025-01191-6.
Col Valerie Sams, MD is an Air Force trauma surgeon, surgical critical care expert, and the Director of the Center for Sustainment of Trauma and Readiness Skills (C-STARS) at the University of Cincinnati. Her path to the operating room was anything but ordinary. Before medical school, she served as an Air Force line officer in logistics and fuels, learning how the operational side of the service actually works at the flight line. That bilingual fluency in operations and medicine now shapes how she advocates for resources, leads hospitals, and prepares the military health system for the next fight. In this conversation, she walks through her two tours as the trauma czar at the Bagram role three hospital straight out of fellowship, where she was responsible not only for clinical excellence but for leading every nurse, emergency medicine physician, and surgeon doing trauma care across the theater. She talks honestly about the weight of that role, especially during her second deployment with junior surgeons on their first downrange experience, the rise in U.S. casualties, the green-on-blue threat, and her work standing up Medic-X as a force multiplier for limited deployed medical crews. Col Sams makes a powerful case for the strategic importance of military-civilian partnerships like C-STARS, the only Air Force critical care air transport advanced training course, and explains how the Air Force, Army, and Navy are converging through the Joint Trauma System, the Mission Zero Act, and the American College of Surgeons Blue Book to professionalize military-civilian integration. She is direct about the skill sustainment crisis inside military treatment facilities, the shift from 65 percent beneficiary care to 20 percent, the urgency of the Military Unique Curriculum, and the need to train outside-the-tent skills deliberately rather than by accident. Dr. Sams lays out a clear-eyed vision for large-scale combat operations: faster trauma registry feedback loops, autonomous and decision support tools, closed-loop control ventilation, ECMO projected forward, and a hard end to the wax pencil and TCCC card as battlefield documentation. She closes with what should remain the center of gravity for every military medicine decision — the warfighter — and the conviction that they deserve the best clinical care available anywhere in the country. Chapters (00:47-05:47) From Fuels Officer to Trauma Surgeon (05:47-12:49) Two Tours as Trauma Czar at Bagram (12:49-24:46) ECMO Forward, C-STARS, and the Skill Sustainment Crisis (24:46-35:42) Joint Military-Civilian Integration and the Military Unique Curriculum (35:42-49:26) LSCO Readiness, Force Multiplication, and Battlefield Technology (49:26-58:30) Female Leadership, Clinical Excellence, and Legacy Chapter Summaries (00:47-05:47) From Fuels Officer to Trauma Surgeon Col Sams describes her unconventional path from Air Force line officer in logistics and fuels to general surgery and trauma fellowship. She credits her operational background with giving her a bilingual fluency between line and medical worlds that strengthens how she advocates for resources, leads hospital operations, and earns credibility with non-medical commanders. (05:47-12:49) Two Tours as Trauma Czar at Bagram She unpacks the weight of deploying as the trauma czar at the Bagram Role 3 immediately after her fellowship and the lessons that came from leading mass casualty events, debriefing young teams, and dealing with the green-on-blue threat. She explains the stand-up of Medic-X under Lt Gen Hogg as a deliberate force multiplier for limited deployed medical crews. (12:49-24:46) ECMO Forward, C-STARS, and the Skill Sustainment Crisis Col Sams details her work projecting ECMO capability into austere environments and around the globe, then explains the mission, history, and structure of the three original C-STARS programs. She is direct about the skill sustainment crisis, with beneficiary care in military treatment facilities dropping from roughly 65 percent to 20 percent over two decades. (24:46-35:42) Joint Military-Civilian Integration and the Military Unique Curriculum She describes the progress driven by the Mission Zero Act, the Joint Trauma System military-civilian work group, and the American College of Surgeons Blue Book. She makes the case for a robust Military Unique Curriculum that develops both surgical fundamentals and the outside-the-tent skills that today's young military surgeons need before they take their first leadership role downrange. (35:42-49:26) LSCO Readiness, Force Multiplication, and Battlefield Technology Col Sams turns to large-scale combat operations and the blind spots that the counterinsurgency generation may carry into the next fight. She calls for faster trauma registry feedback, autonomous decision support tools, closed-loop ventilation, ECMO projected forward, and a hard end to the TCCC wax pencil as the primary battlefield documentation tool. (49:26-58:30) Female Leadership, Clinical Excellence, and Legacy She offers candid advice to young female military surgeons on imposter syndrome, unconscious bias, and the discipline of staying clinically excellent. She closes with the conviction that patient-centered leadership, lifelong learning, and protecting clinical talent are the foundations of how military medicine should remember her work. Take Home Messages Operational Fluency Strengthens Medical Leadership: Time spent on the line side of the military — understanding logistics, fuels, and how the operational force actually fights — builds credibility with non-medical commanders and sharpens advocacy for resources. Surgeons who speak the operational language sit at the right tables and make better decisions for their teams and their patients. The Trauma Czar Role Demands Leadership Before Stride: Being responsible for an entire theater of combat casualty care immediately after fellowship is a heavy and unforgiving assignment. Clinical excellence is the floor; the real work is leading nurses, emergency medicine physicians, and surgeons through mass casualty events, debriefs, and the green-on-blue threat with junior teammates who have never deployed before. Skill Sustainment Requires Military-Civilian Partnership: Military treatment facilities now deliver only a fraction of the beneficiary care they once did, and that volume cannot sustain combat-ready trauma teams. Embedded military-civilian partnerships like C-STARS, supported by the Mission Zero Act and the American College of Surgeons Blue Book, are the realistic path to keep wartime skills sharp. Outside-the-Tent Skills Must Be Deliberately Trained: Today's young military surgeons need more than technical readiness. They need a deliberate Military Unique Curriculum that develops the non-clinical leadership skills required to run a theater trauma system, manage resources, and lead teams under pressure. Picking those skills up on the fly is no longer good enough. LSCO Will Not Wait on the Wax Pencil: The next fight will not give the medical force three years to figure out what changed or seven years to update clinical practice guidelines. Force multiplication through MedicX, autonomous decision support tools, closed-loop ventilation, ECMO projected forward, and modern battlefield documentation are non-negotiable investments now, before large-scale combat operations force the lesson. Col Valerie Sams, MD Biography Colonel Valerie Sams is the Director of the Center for Sustainment of Trauma and Readiness Skills (CSTARS) Cincinnati and serves as Critical Care Air Transport Team (CCAT) Training cadre. Originally from Georgetown, KY, she was commissioned into the Air Force in 2000, initially serving as a supply and logistics officer, which included a deployment supporting Stabilization Forces in the Balkans. Transitioning to medicine, she earned her medical degree from St. George's University in 2008. Col Sams completed her General Surgery Residency at the University of Tennessee Medical Center (2013) and a Trauma Critical Care fellowship at Brooke Army Medical Center (2015). As a trauma surgeon and ECMO physician, Col Sams deployed twice as the Trauma Czar for Bagram Airfield, Afghanistan. Her extensive leadership roles include Trauma Medical Director, Assistant Chief of Trauma and Surgical Critical Care, Ground Surgical Team Pilot Unit Leader, and director of various military trauma research programs. Episode Keywords WarDocs, military medicine, military trauma surgery, combat casualty care, trauma czar, Bagram role three, Air Force trauma surgeon, C-STARS Cincinnati, critical care air transport, CCATT, Joint Trauma System, military civilian partnership, Mission Zero Act, military unique curriculum, large scale combat operations, LSCO, prolonged casualty care, MedicX, ECMO in combat, battlefield documentation, TCCC card, closed loop ventilation, military medical leadership Hashtags #MilitaryMedicine, #WarDocs, #CombatCasualtyCare, #TraumaSurgery, #JointTraumaSystem, #LSCOReadiness, #CSTARS, #MilCivPartnership Honoring the Legacy and Preserving the History of Military Medicine WarDocs exists to honor the legacy of Military Medicine, preserve its history, and inspire every generation — across all Services, Corps, and Ranks — to serve with excellence and pride. Through mentorship, coaching, and education, we equip those considering, entering, and serving in military medicine with the knowledge, connections, and community they need to thrive. We celebrate Who we are, What we do, and, most importantly, How we serve Our Patients, the DoW, and Our Nation. Find out more and join Team WarDocs at https://www.wardocspodcast.com/ Check our list of previous guest episodes at https://www.wardocspodcast.com/our-guests Subscribe and Like our Videos on our YouTube Channel: https://www.youtube.com/@wardocspodcast Listen to the “What We Are For” Episode 47. https://bit.ly/3r87Afm WarDocs- The Military Medicine Podcast is a Non-Profit, Tax-exempt-501(c)(3) Veteran Run Organization run by volunteers. All donations are tax-deductible and go to honoring and preserving the history, experiences, successes, and lessons learned in Military Medicine. A tax receipt will be sent to you. WARDOCS documents the experiences, contributions, and innovations of all military medicine Services, ranks, and Corps who are affectionately called "Docs" as a sign of respect, trust, and confidence on and off the battlefield, demonstrating dedication to the medical care of fellow comrades in arms. Follow Us on Social Media Twitter: @wardocspodcast Facebook: WarDocs Podcast Instagram: @wardocspodcast LinkedIn: WarDocs-The Military Medicine Podcast YouTube Channel: https://www.youtube.com/@wardocspodcast
Dr. Howard Schubiner is an internist and pediatrician, who attained the rank of full Professor at Wayne State University School of Medicine in 1999. He is an internist and the director of the Mind Body Medicine Center at Ascension Providence Hospital in Southfield, Michigan. Dr. Schubiner is a Clinical Professor at the Michigan State University College of Human Medicine and is a fellow in the American College of Physicians, and the American Academy of Pediatrics. He has authored more than 100 publications in scientific journals and books, and lectures regionally, nationally, and internationally. Dr. Schubiner is the author of three books: Unlearn Your Pain, Unlearn Your Anxiety and Depression, and Hidden From View, written with Allan Abbass, MD, a Professor of Psychiatry at Dalhousie University in Halifax, Nova Scotia. Today, we have a fascinating conversation on Mind Body Syndrome a condition where the brain generates very real physical pain or symptoms in response to unresolved emotional stress, trauma, or repressed feelings like anger and anxiety. Learn more about your ad choices. Visit megaphone.fm/adchoices
May is Older Americans Month, a time to celebrate older adults, recognize advocates supporting aging communities, and embrace the journey to healthy aging. It's also Physical Fitness and Sports Month and Mental Health Awareness Month, making this the perfect time to explore the connection between fitness and healthy aging with four-time reigning California's Strongest Man and physician, Dr. Andrew Mock.When Dr. Mock isn't pulling 16-wheelers or lifting 225-pound scuba tanks, he's promoting health, wellness, and longevity as Director of the American College of Lifestyle Medicine Residency Curriculum. Throughout his career, he has championed the long-term benefits of exercise and made it his mission to lead by example. Join us as we discuss the many benefits of movement and share simple ways to begin your own fitness journey.
Are your workouts actually building strength or just burning time? Amy Hudson and Dr. James Fisher break down the latest 2026 guidelines from the American College of Sports Medicine on how you should be training today. They unpack why consistency beats perfection, how minimal training can still deliver real results, and where most people waste time and effort. Tune in to simplify your approach and start training in a way that actually works.Dr. Fisher explains what the American College of Sports Medicine (ACSM) actually does. It's one of the main bodies shaping exercise science, from research journals to certifications that guide the industry.Dr. Fisher shares why resistance training is still massively underused. Around 60% of adults aren't doing any strength work, and only a small percentage hit the basic guideline of twice per week.Learn why consistency will always beat the “perfect program.” You don't need the smartest plan on paper if you're not showing up for it. What actually moves the needle is turning up regularly and putting in some effort, even on the days it feels basic.Amy covers how to choose a program you'll actually stick with. There's no shortage of “best” routines out there, but most of them fail because people don't follow through. The real win is picking something that fits your life so well that skipping it starts to feel uncomfortable.Dr. Fisher explains how to progress your training without overthinking it. If the weight, reps, or sets aren't gradually increasing, your body has no reason to adapt. Progress doesn't have to be dramatic, but it does need to be intentional.Amy covers why a personal trainer can quietly make all the difference. Most people fall into the habit of repeating the same weights and routines because it feels comfortable. A good personal trainer steps in to push progression just enough to keep you improving without burning out.Learn how working with a personal trainer improves more than just your results. You're not just getting guidance, you're also getting accountability, structure, and a reason to show up. That consistency alone is often what separates people who see change from those who stay stuck.Dr. Fisher explains why resistance training feels complicated (but isn't). Many people avoid it because they're unsure where to start or think it takes too much time. In reality, even two short 20-minute sessions a week can deliver meaningful results if done properly.Amy covers how to keep strength training simple and effective. Building strength is naturally repetitive. You don't need constant variety; you need consistency in doing what already works.Amy and Dr. Fisher agree that the basics will always outperform every “new hack.” Sleep well, eat decently, and challenge your muscles regularly is the foundation. Amy adds that it's easy to chase complexity, but most results come from doing simple things well over time.Dr. Fisher explains how eccentric overload can unlock more strength. Traditional weights give you the same resistance up and down, which limits how much you can challenge the muscle. With advanced tech like exerbotics devices, the lowering phase can match your strength more closely, creating a stronger stimulus and better results. Mentioned in This Episode:The Exercise Coach - Get 2 Free Sessions!Submit your questions at StrengthChangesEverything.com This podcast and blog are provided to you for entertainment and informational purposes only. By accessing either, you agree that neither constitute medical advice nor should they be substituted for professional medical advice or care. Use of this podcast or blog to treat any medical condition is strictly prohibited. Consult your physician for any medical condition you may be having. In no event will any podcast or blog hosts, guests, or contributors, Exercise Coach USA, LLC, Gymbot LLC, any subsidiaries or affiliates of same, or any of their respective directors, officers, employees, or agents, be responsible for any injury, loss, or damage to you or others due to any podcast or blog content.
Modern family offices, private trust companies, and purpose trusts: governance, tax considerations, and legacy planning strategies for ultra-high-net-worth families. The American College of Trust and Estate Counsel, ACTEC, is a professional society of peer-elected trust and estate lawyers in the United States and around the globe. This series offers professionals best practice advice, insights, and commentary on subjects that affect the profession and clients. Learn more in this podcast.
AI is already shaping the most personal part of your life: how you understand your body, your symptoms, and your next healthcare decision. We sit down with Dr. Ami Bhat, a board-certified cardiologist, Chair of the FDA Digital Health Advisory Committee, and Chief Innovation Officer at the American College of Cardiology, to translate the hype into practical, human-first guidance you can actually use.We talk about hybrid care and why the “first mile” of healthcare belongs at home, where real life happens. Dr. Bhat explains how to find your own baseline for blood pressure, sleep, and heart rate, how trends can reveal early warning signs, and how AI can help clinicians handle medical information overload without replacing the clinician-patient relationship.We also get specific about tools: wearables, voice-to-text documentation that lets doctors stop staring at screens, and health-focused large language models designed for clinical use. Then we tackle the hard parts: health anxiety spirals, AI mistakes, and women's cardiovascular health where heart attack symptoms can be atypical and too often dismissed. We close with a clear argument for chronic disease management at home to reduce ER bottlenecks and protect quality of life. If you want a smarter way to use AI in healthcare without getting misled, hit play. Subscribe, share this with someone managing a chronic condition, and leave a review with the one health metric you want to understand better.You can find Dr. Ami Bhatt at:Website - https://dramibhatt.com/Send us your desired health topic or guest suggestions Please Follow and Review this podcast if you would like to support the growth of this show. Thank You! :)If you enjoyed this episode, please consider sharing it with two people you know that might benefit from the information. The more knowledge that people have in their hands, the healthier we can all become. If you would like to see a particular health issue discussed, or know someone who would be a great guest, contact the Open-Minded Healing podcast at marla@openmindedhealing.com. Note: By listening to this podcast, you agree not to use this podcast as medical advice to treat any medical condition in either yourself or others, including but not limited to patients that you are treating. Consult your own physician for any medical issues that you may be having. This entire disclaimer also applies to any guests or contributors to the podcast. Under no circumstances shall Marla Miller, Open-Minded Healing Podcast, any guests or contributors to the podcast, be responsible for damages arising from use of the podcast.
My talk with Skye begins at 26 mins Subscribe and Watch Interviews LIVE : On YOUTUBE.com/StandUpWithPete ON SubstackStandUpWithPete Stand Up is a daily podcast. I book,host,edit, post and promote new episodes with brilliant guests every day. This show is Ad free and fully supported by listeners like you! Please subscribe now for as little as 5$ and gain access to a community of over 750 awesome, curious, kind, funny, brilliant, generous souls Skye L. Perryman is the President and CEO of Democracy Forward, a nonpartisan, national legal organization that promotes democracy and progress through litigation, regulatory engagement, communications, policy education, and research. Named as one of the 2025 100 Most Influential People In The World by TIME Magazine, Ms. Perryman took the helm at Democracy Forward a few months after January 6, 2021, in the midst of rising extremism in communities and courts across the country. She has built a visionary team of legal, policy, and communications experts to confront anti-democratic extremism head-on while also using the law to advance progress and a bold vision for the future. Under Ms. Perryman's leadership, Democracy Forward has expanded the scope and reach of its work, emerging as a nationally recognized institution that is taking on the most significant issues affecting people, families, and communities– from defending civil rights and fair wages to seeking to expand access to reproductive health care post-Dobbs to confronting attacks on education to addressing the climate crisis and much more. Since January 2025, Democracy Forward has played a leading role in inspiring courage and in protecting the American people from harmful and unlawful federal executive action. The organization has filed hundreds of legal actions, launched hundreds of investigations, and, through its Democracy 2025 initiative, has organized the largest, most successful affirmative litigation effort against executive branch excesses in United States history. Learn more about our work here. Known for her strategic insight and impact-oriented leadership, Ms. Perryman has a track record of winning tough legal and policy battles, uniting diverse coalitions, inspiring the American public, and elevating voices that represent the fabric of our country to deliver results that improve the lives of millions. Over the course of her nearly two decade legal career, Ms. Perryman has served in executive positions and has provided legal and strategic counsel for a broad range of clients and institutions. She previously served as Chief Legal Officer and General Counsel of the American College of Obstetricians and Gynecologists. There, she oversaw legal and policy strategies that resulted in historic advancements in access to health care for women, including developing strategies to support the extension of postpartum Medicaid coverage for more than 500,000 people, overseeing litigation that enabled the distribution of mifepristone by mail for the first time in US history, launching an industry-wide effort to address racism and promote racial equity in medicine, and leading comprehensive legal and policy responses to the COVID-19 pandemic. Ms. Perryman was previously a member of Democracy Forward's founding legal team and began her legal career in litigation roles at WilmerHale and Covington & Burling, where she gained the trust of clients in the health care, financial services, education, and consumer products industries while simultaneously maintaining an active pro bono practice, receiving numerous commendations and awards for her work. Ms. Perryman's work has been recognized widely for its positive impact on people and communities. She has received numerous awards and recognitions for her commitment to public service and her professional work, including receiving a Lifetime Award Award for the Pursuit of Justice from the Georgetown University Law Center's O'Neill Institute, being named one of the 500 Most Influential People Shaping Policy by Washingtonian Magazine for consecutive years, one of The NonProfit Times's Power & Influence Top 50 and their 2025 Influencer of the Year, the 2025 Resister in Law by the Feminist Majority Foundation, a Woman to Watch by the New Republic, a Chuck F C Ruff Pro Bono Lawyer of the Year recipient, a Sissy Farenthold Social Justice Award recipient, a Harry S. Truman Scholar (2002), a Baylor Line Foundation Outstanding Young Alumni (2018), and a four-time Rising Star in Litigation in Washington, DC, among other awards. Ms. Perryman is a frequent guest lecturer and keynote speaker on matters at the intersection of law and policy. She has testified before the U.S. Congress and other expert bodies and her legal work has been cited by the U.S. Supreme Court as well as state supreme courts. Ms. Perryman appears on both network and cable television and her work and commentary is routinely covered in outlets such as The New York Times, NPR, NBC News, The Washington Post, Texas Monthly, The Houston Chronicle, Teen Vogue, MSNBC and CNN. Ms. Perryman grew up in Waco, Texas and is a proud product of K-12 public education. She holds a Bachelor of Arts in Economics and Philosophy magna cum laude from Baylor University where she was elected to Phi Beta Kappa and a Juris Doctor with honors from the Georgetown University Law Center where she served as an Editor for the American Criminal Law Review and was an Editor in Chief for the ACLR's Annual Survey on White Collar Crime. Ms. Perryman serves on the boards of the Interfaith Alliance, the Atlas Performing Arts Center, the Texas Observer, the Baylor Line Foundation, and the Rise Up: Federal Workers Legal Defense Network. Alongside both progressive and conservative legal scholars, she co-chairs We Hold These Truths, Democracy Forward's initiative to provide accessible civic education to the American public. Listen rate and review on Apple Podcasts Listen rate and review on Spotify Pete On Instagram Pete on Blue Sky Pete on Threads Pete on Tik Tok Pete on Twitter Pete Personal FB page Stand Up with Pete FB page Gift a Subscription https://www.patreon.com/PeteDominick/gift Send Pete $ Directly on Venmo All things Jon Carroll Buy Ava's Art Subscribe to Piano Tuner Paul Paul Wesley on Substack Listen to Barry and Abigail Hummel Podcast Listen to Matty C Podcast and Substack Follow and Support Pete Coe Hire DJ Monzyk to build your website or help you with Marketing
In this episode, CardioNerds Dr. Colin Blumenthal, Dr. Kelly Arps, and Dr. Yong Hao Yeo are joined by electrophysiology expert Dr. Bradley Knight to discuss atrial fibrillation (AF) management in challenging clinical scenarios. We explore arrhythmias in patients with pre-excitation syndromes, particularly Wolff-Parkinson-White (WPW) syndrome, and strategies for rhythm control. We also discuss AF management in pregnancy, adult congenital heart disease, and patients with tachycardia-bradycardia (tach-brady) syndrome. This episode provides essential insights into nuanced decision-making for the care of patients with complex arrhythmia profiles. Audio editing by CardioNerds academy intern, Grace Qiu. Enjoy this Circulation 2022 Paths to Discovery article to learn about the CardioNerds story, mission, and values. CardioNerds Atrial Fibrillation PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll CardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron! PEARLS AF in WPW is a true emergency—AV nodal blocking agents can be deadly. In patients with WPW syndrome, AF can rapidly conduct through the accessory pathway, risking ventricular fibrillation and sudden death. Avoid AV nodal blockers like beta-blockers and calcium channel blockers. Catheter ablation is the first-line rhythm control strategy in WPW. Catheter ablation carries a Class I recommendation and offers >90% success. If antiarrhythmic drugs are needed, sodium channel blockers like flecainide or propafenone are preferred in patients without structural heart disease. In pregnancy, protecting the mother is protecting the fetus. An unstable mother means an unstable fetus. Rate control is the first step in AF with rapid ventricular responses and electrical cardioversion is safe when needed. Multidisciplinary care is essential. AF in congenital heart disease is often outside the pulmonary veins. Surgical scars and chamber remodeling in ACHD patients often lead to AF from non-pulmonary vein foci. Electrogram-based mapping and targeted ablation strategies are essential to increase success rate of durable rhythm control. Tachy-brady syndrome may require pacing to unlock therapy. AF may cause atrial myopathy and sinus node dysfunction. These patients often require permanent pacing to allow safe use of rate-controlling medications like beta-blockers and to prevent syncope or chronotropic incompetence. Notes: Notes drafted by Dr. Yong Hao Yeo Why is atrial tachycardia in patients with WPW syndrome dangerous? Patients with WPW commonly present with supraventricular tachycardia (SVT) due to atrioventricular reentrant circuits, either orthodromic or antidromic. This SVT can degenerate into AF. In the absence of AV nodal as the governor between the atrium and ventricles, the accessory pathway may conduct impulses rapidly and frequently. This can lead to dangerously high ventricular rates, predisposing patients to ventricular fibrillation and sudden cardiac arrest. What are some strategies for rhythm control in patients with WPW and atrial tachycardia? Catheter ablation is the first-line therapy (Class I recommendation), with a success rate of over 90%. Ablation reduces the risk of sudden cardiac arrest, though some patients may remain prone to AF. If ablation is not feasible/ contraindicated, sodium channel blockers such as flecainide and propafenone are good options in patients without ischemia or structural heart disease (Class IIa recommendation). Amiodarone should be avoided because it has a long half-life, can accumulate in the system, and may delay definitive treatment with catheter ablation. AV nodal blocking agents like beta blockers and calcium channel blockers should be avoided, as they are less effective at controlling ventricular rate in WPW and can increase conduction over the accessory pathway. These agents can also exacerbate the risk of rapid ventricular rates during AF and worsen left ventricular function. What are some special considerations in managing AF in pregnant patients? The primary goal in managing cardiovascular disease during pregnancy is to protect the mother, as fetal outcomes depend on maternal well-being. Therefore, while caution is necessary, we should avoid undertreating pregnant patients with AF. In cases of AF with rapid ventricular response (RVR), rate control is usually the first-line strategy, with beta blockers preferred over digoxin or non-dihydropyridine calcium channel blockers. It is then reasonable to initially observe for spontaneous conversion in stable patients. Antiarrhythmic drugs (AADs) are generally avoided during the first trimester, but clinical judgment on a case-by-case basis is essential. Evidence for the safety of AADs in pregnancy is limited, often derived from their use in other conditions such as fetal SVT. Flecainide and sotalol are reasonable options for rhythm control (Class IIa recommendation). Electrical cardioversion is considered safe in pregnancy and should be utilized when indicated (Do not forget!). There is no pregnancy-specific thromboembolic risk stratification tool. CHA₂DS₂-VASc scoring and the presence of risk factors like mitral stenosis can help guide anticoagulation decisions, though the magnitude of thromboembolic risk during pregnancy remains unclear. Rate control agents are typically continued during delivery due to the increased physiologic stress of labor and delivery. Multidisciplinary care is crucial and should involve obstetrics, maternal-fetal medicine, cardiology, and electrophysiology specialists. What are some key considerations for AF management in patients with adult congenital heart disease (ACHD)? Patients with repaired congenital heart disease are at increased risk for arrhythmias due to two main factors: surgical scars that create arrhythmogenic foci and mechanical remodeling of the atria or ventricles resulting from the underlying disease. In these patients with structural heart disease, sodium channel blockers may not be ideal antiarrhythmic options. When selecting an antiarrhythmic drug, clinicians must consider the nature of structural or surgical impairments, such as right bundle branch block or prolonged QT interval. It is also essential to assess renal and hepatic function (often impaired in patients with ACHD) to ensure appropriate metabolism and clearance of antiarrhythmic medications. Electrogram-based ablation strategies (those leveraging artificial intelligence are developing!) may help identify effective ablation targets, which are often outside the pulmonary veins in patients with ACHD. These individualized approaches can improve ablation success rates in this complex patient population. What makes tachycardia-bradycardia (tach-brady) syndrome a unique challenge in arrhythmia management? Patients who present with both AF and bradycardia, especially with syncope, require a thoughtful diagnostic approach to identify the underlying rhythm disturbance. Extended cardiac monitoring, including event monitors or implantable loop recorders, can help capture intermittent arrhythmias and correlate them with symptoms. AF may lead to atrial myopathy, and since the sinus node resides within the atrium, this can result in sinus node dysfunction—a hallmark of tachy-brady syndrome. Following spontaneous conversion from AF to sinus rhythm, sinus node dysfunction may persist, leading to prolonged pauses or chronotropic incompetence. Management becomes more complex when beta-blockers are needed for AF with RVR, as they can exacerbate bradycardia. Permanent pacemaker implantation is often the next step to consider. Permanent pacemaker implantation is often considered to facilitate safe rate control in these cases. In younger patients, aggressive AF burden reduction may prevent atrial remodeling and the development of true atrial myopathy, potentially avoiding pacemaker implantation. References Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2023;149(1). doi:https://doi.org/10.1161/CIR.0000000000001193 Van IC, Rienstra M, Bunting KV, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2024;45(36). doi:https://doi.org/10.1093/eurheartj/ehae176 Joglar JA, Kapa S, Saarel EV, et al. 2023 HRS expert consensus statement on the management of arrhythmias during pregnancy. Heart Rhythm. Published online May 1, 2023. doi:https://doi.org/10.1016/j.hrthm.2023.05.017 Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary. Journal of the American College of Cardiology. 2019;73(12):1494-1563. doi:https://doi.org/10.1016/j.jacc.2018.08.1028
We speak with David Blanchette about his career, both in research and in investment management for individual investors. We talk about his public tiff with finfluencer Dave Ramsey, common investment mistakes, some surprising results from his research, and, of course, the only dirty word in finance. David is Head of Retirement Research with Prudential Financial, and a Portfolio Manager for PGIM. He is a CFA charterholder, holds a BBA from the University of Kentucky, MSFS in Financial Services from The American College of Financial Services, an MBA in Analytic Finance from Chicago Booth, and a Ph.D. In Personal Financial Planning from Texas Tech University. What David is Reading Right Now: Your Future Self: How to Make Tomorrow Better Today by Hal Hershfield David's Music Recommendation: "Self Destructor" by Chevelle ___ Join Us At The Private Wealth Leadership Forum: October 1-2, 2026 | Westin, Las Colinas CFA Institute and CFA Society Dallas/Fort Worth will convene CIOs, portfolio managers, advisors, and family office leaders for a 1.5-day event exploring how investment strategies are evolving. Attendees will gain practical insights into integrating private markets and alternatives into portfolios, managing liquidity and risk, improving tax efficiency, adapting advisory models amid consolidation and technological change, and guiding clients through liquidity events and generational wealth transitions. Click Here To Register Member exclusive discount: CFA Society Dallas/Fort Worth members, you can use one of your $40 discounts to this event! Email us at info@cfadfw.org for more information. ___ Get updated when new episodes release by joining our list: https://bit.ly/4dwwTgD Connect with CFA Society Dallas/Fort Worth: LinkedIn | Instagram| www.cfasociety.org/dallasfortworth
This week Kate, Mark and Henry talk about empathetic robots, mother-baby singing groups for postpartum depression, and new American College of Cardiology lipid guidelines.Indiana AFP POEMs course in French Link: https://www.iafp.org/2026ac Empathetic robots: https://pubmed.ncbi.nlm.nih.gov/41359230/ Weekly singing groups for postpartum depression: https://pubmed.ncbi.nlm.nih.gov/41087020/ACC/AHA/etc lipid guidelines: https://pubmed.ncbi.nlm.nih.gov/41824552/A 2025 study in the journal Family Practice finding that the two most trustworthy lipid guidelines recommended against using CAC, while all five less trustworthy guidelines due to poor methods or COI recommended it. Go figure.Smartphones in schools: https://pubmed.ncbi.nlm.nih.gov/41489912/
"Defining a new 6-factor Charlson Comorbidity Index utilizing data points available in the American College of Surgeons National Surgical Quality Improvement Program for patients undergoing pancreatoduodenectomy"
It's In The News, where we bring you the top diabetes stories and headlines happening now. Top stories this week: Dexcom shares details of its next generation CGM, T1D and GLP-1 studies, weight loss management on GLP-1 medications updates, all-in-one CGM and pump, and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com Episode transcript: XX Dexcom announces some features of it's next generation CGM – the G8. We've been talking about this with CEO Jake Leach for a while now – it will be a 50% smaller with what they're calling advanced sensing capabilities. According to Leach, G8 will adapt to the physiologic variability of each user. It has additional technology built in, based on a new silicon chip design and algorithm. 15 day wear is now the baseline for all Dexcom sensors moving forward. At launch the G8 will only measure glucose but the plan is for a multi-analyte version to follow. That would measure ketones and potassium. Ketones we know – but potassium is very important for people with kidney and possible for people taking some diabetes meds. It's an interesting space to watch.. btw, analyte is just a medical word for the specific thing you're measuring – the target of the test you're running. we're going to hear that word a lot I think.. Looks like an FDA submission for the G8 next year.. with an outside the US launch the following year. https://www.drugdeliverybusiness.com/dexcom-unveils-next-gen-g8-cgm/ XX Glucotrack has submitted its implantable continuous blood glucose monitor (CBGM) for FDA IDE, that's investigational device exemption and would enable the company to initiate a U.S. clinical study for the fully implantable technology. Rutherford, New Jersey-based Glucotrack's device features no on-body external component. The company aims to offer it for three years of continuous, accurate blood glucose monitoring for a more convenient, less intrusive solution. Unlike traditional CGMs that measure glucose in interstitial fluid, the CBGM measures glucose levels directly from the blood. The implant goes five centimeters within the subclavian vein. Glucotrack's active implantable device has a small battery and some electronics that go just under the skin in the pectoral region. The location of the implant is not in a major vessel, but the implant can measure real-time glucose levels as pulsatile blood flows over the tip of the sensor. https://www.drugdeliverybusiness.com/glucotrack-submits-long-term-implantable-cbgm-fda-ide/ XX PharmaSens today announced the publication of data from the first clinical study evaluating its all-in-one insulin patch pump offering. The all-in-one pump pairs the Niaa Essential insulin patch pump with the SynerG continuous glucose monitor (CGM) sensor developed by Pacific Diabetes Technologies. However, this system would be one device that features both the pump and CGM technology. PharmaSens and SiBionics also have a collaboration aimed at developing the all-in-one solution. They are jointly developing the next-generation Niia insulin patch pump with a SiBionics CGM. PharmaSens expects a second feasibility study in the second quarter to evaluate the next-generation pump with SiBionics' CGM. PharmaSens says the clinical feasibility study of Niia demonstrated for the first time ever that the combined offering is, in fact, feasible. It believes its device addresses the need for alternatives to multi-device diabetes management. systems. Aggregated MARD for the investigational device came in at 11.6%. A MARD target of less than 10% is considered ideal for CGM devices, but PharmaSens said that, in the context of the early feasibility study, the results were encouraging and provide evidence supporting the development of an all-in-one system. https://www.drugdeliverybusiness.com/pharmasens-efs-insulin-patch-pump-cgm/ XX XX ViCentra launches the newest version of the Kaleido pump system in Europe. This is that small colorful pump, with Diabeloops algorithm and the Dexcom G7. It'll be in Germany and the Netherlands later this summer. https://hellokaleido.com/vicentra-announces-commercial-launch-of-new-smartphone-controlled-kaleido-automated-insulin-delivery-patch-pump-system/-- XX Diabeloop just got CE Mark approval for DBLG2 integrations – it's latest AID platform the company has kicked off the gradual European launch of the technology. It currently offers DBLG2 as a smartphone application on Android, with iOS integration coming soon. As you just heard, it's integrated with kaleido and the company says it plans to make additional configuration for DBLG2 with alternative pumps "available soon." Running on a user's smartphone, DBLG2 works as a self-learning algorithm. It continuously analyzes glucose data, calculates insulin needs in real time and automatically adjusts delivery. https://www.drugdeliverybusiness.com/diabeloop-fda-next-gen-algorithm-g7/ XX Among adults with type 1 diabetes (T1D), the initiation of GLP-1-based therapy was associated with a lower risk for all-cause death, several cardiovascular outcomes, all-cause hospitalisations, and hypoglycaemia, without a higher risk for diabetic ketoacidosis. METHODOLOGY: Researchers in Greece conducted a retrospective cohort study utilising real-world data from a global health research network to evaluate the association between GLP-1-based therapy and cardiovascular and renal outcomes in adults with T1D. A total of 4088 patients receiving GLP-1-based therapies (median age, 43 years; 34.3% men) were propensity score matched with an equal number of patients not receiving the treatment. The risk for hypoglycaemia was lower with GLP-1-based therapy (hazard ratio, 0.72; P = .021); however, the risk for diabetic ketoacidosis did not differ significantly between the two groups. https://www.medscape.com/viewarticle/glp-1-drugs-tied-cardiovascular-benefits-t1d-2026a1000fbx XX Eli Lilly and Company (NYSE: LLY) today announced detailed results from two late-phase trials showing that people with obesity maintained their weight loss long term with either Foundayo or lower-dose Zepbound after switching from higher doses of injectable incretin therapy. The findings from SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN, were presented at the 33rd European Congress on Obesity (ECO) and published in The Lancet and Nature Medicine, respectively. "Weight regain remains one of the biggest challenges in obesity care, and is often the result of treatment interruptions that cause biology to work against patients, undoing the progress they've made," said Louis J. Aronne, M.D., FACP, DABOM, founder and Chair Emeritus of the American Board of Obesity Medicine, former president of The Obesity Society, Fellow of the American College of Physicians, world-renowned obesity specialist and Lilly consultant. "These medicines can be used for long-term maintenance today, and results from SURMOUNT-MAINTAIN and ATTAIN-MAINTAIN provide additional evidence of their potential when switching from higher doses of injectable incretin therapy." https://investor.lilly.com/news-releases/news-release-details/lillys-foundayo-and-lower-dose-zepbound-helped-people-maintain XX Scientists in Sweden have developed a more reliable way to create insulin-producing cells from human stem cells. These lab-grown cells not only respond strongly to glucose but were also able to restore blood sugar control when transplanted into diabetic mice. When transplanted into diabetic mice, the cells gradually restored the animals' ability to regulate blood sugar. Long way to go, as we say with most of these mice studies. https://www.sciencedaily.com/releases/2026/05/260505234620.htm XX Interesting look at how the body controls sugar storage – apparently this finding challenges long-standing biology concepts and could open new directions for disease treatment. Published in Nature, the study describes a potential method for directly reducing glycogen, the stored form of sugar in the body. These scientists discovered that glycogen can be directly regulated by ubiquitin, a protein best known for marking damaged proteins for recycling or removal. The study is the first to show that ubiquitin can regulate glycogen in humans, overturning more than 50 years of scientific understanding. Excess glycogen is also associated with more common health problems, including diabetes, obesity, liver disease, and heart disease. https://scitechdaily.com/scientists-just-rewrote-biology-hidden-mechanism-could-transform-diabetes-treatment/ XX A new Oklahoma law will give parents the option to have their children screened for Type 1 Diabetes. The measure passed with overwhelming bipartisan support in the Legislature and takes effect Nov 1. Oklahoma consistently ranks among the states with the highest rates of diabetes and diabetes-related deaths. The law gives parents access to antibody testing that can detect risk years before symptoms develop, helping families take preventive action and avoid emergency room visits. https://journalrecord.com/2026/05/11/oklahoma-law-expands-access-type-1-diabetes-screening/ XX More to come including a new study trying to figure out why some people are more likely to develop diabetes, a look at cannabis and preventing metabolic disorders, and XX A National Institutes of Health (NIH)-funded study has identified key differences in human pancreatic islet cells that may help explain why some people are more likely to develop diabetes. Researchers found that the mix of hormone-producing cells in the pancreas varies widely from person to person, and that variation plays a central role in how the body regulates blood sugar. The study involved a deep dive into islet cell function that is linked to donor traits associated with observable characteristics, or phenotype, such as sex, race and ethnicity, as well as genetic information, or genotype, including predicted ancestry and genetic risk for both type 1 and type 2 diabetes. The findings highlight that islet cell composition, rather than the physical size and shape of islets, is a key factor in regulating hormone release. The team found that the makeup of pancreatic islets plays a major role in how effectively they release insulin and glucagon — key hormones that regulate blood glucose. Islets with a higher proportion of insulin-producing beta cells showed stronger insulin secretion in response to various stimuli, while higher levels of alpha and delta cells were generally linked to reduced insulin output. In addition, the researchers found that islet hormone secretion is affected by donor traits, such as sex, race and ethnicity and their genetic makeup, including ancestry predicted from genetic testing and genetic risk for type 2 diabetes. Combined, the findings of the study have significant implications for understanding the factors that may predispose people to diabetes. "This study is the tip of the iceberg," said Dr. Evans-Molina. "We hope this dataset becomes useful to the entire diabetes research community and that researchers use it to answer questions about the genotype-phenotype correlation within these data." https://www.nih.gov/news-events/news-releases/nih-funded-study-maps-human-pancreatic-islet-cells-offering-new-clues-diabetes-risk XX XX XX Research published recently in JAMA Network Open offers illuminating evidence suggesting there is a positive association between GLP-1 agonists—drugs commonly used to treat obesity and diabetes—and better outcomes among breast cancer patients. "This study suggests that GLP-1 drugs may offer protective benefits potentially improving survival and recurrence risk in some female patients with breast cancer – whether this is related to weight control, improve cardiovascular health or other mechanisms remains to be studied," said study senior author Bernard F. Fuemmeler, Ph.D., MPH, associate director for population sciences and the Gordon D. Ginder, M.D., Chair in Cancer Research at VCU Massey Comprehensive Cancer Center. Breast cancer patients who are also obese or have type 2 diabetes experience more aggressive cancer growth and worse outcomes. Prior studies have shown that weight loss treatment and surgery following a breast cancer diagnosis are associated with improved heart health and increased survival. What are GLP-1 drugs? Glucagon-like peptide-1 receptor agonists (GLP-1 RAs). Approved to treat type 2 diabetes in 2005 and weight management in 2021. Impacts on breast cancer survival and recurrence are still unclear. Since 2020, the use of these drugs has increased dramatically, where approximately 12% of Americans have used GLP-1s for weight loss, according to a RAND report. The research findings Through a retrospective cohort study examining the electronic health records of more than 840,000 breast cancer patients who were diagnosed between 2006 and 2023, the results suggest there is a potential link between GLP-1 RAs and improved outcomes among breast cancer patients who are also obese or have type 2 diabetes. GLP-1 RA use was associated with an overall lower risk of death from any cause over a 10-year follow-up period among breast cancer patients. Additionally, breast cancer survivors who used GLP1-RAs for diabetes or obesity had a significantly lower risk of their cancer returning over 10 years following their initial treatment. "Our findings align with emerging preclinical research and contribute to a growing body of literature related to GLP-1 RA use in oncology settings," said study lead author Kristina L. Tatum, PsyD, MS, of the VCU School of Public Health. What's next? Further studies are needed to understand the biological mechanisms, if any, between GLP-1 RAs and breast cancer outcomes. The research team intends to further evaluate these correlations through randomized clinical trials. "Our study underscores the potential of GLP-1 RAs as an adjunct strategy for improving cancer-related outcomes among patients with breast cancer, although clinical trials are needed to inform effective therapeutic approaches and clinical decision making," Fuemmeler said. https://www.oncology-central.com/could-glp-1-receptor-agonists-improve-outcomes-for-breast-cancer-patients-with-obesity-or-with-type-2-diabetes/ XX Researchers at UC Riverside gave cannabis to obese mice and found that not only did the rodents lose weight, but when given a concentrated cannabis oil, the mice also saw striking benefits in their metabolic function. DiPatrizio said his team studied the issue to better understand why cannabis users show significant reductions in weight and risk for diabetes compared with nonusers. "We would think that chronic cannabis users would be eating more and weigh more, but it's just the opposite," DiPatrizio said. Scientists are increasingly examining the possibility that cannabis compounds could fight obesity or metabolic disorders like diabetes. Cannabinoids interact with the body's endocannabinoid system, which partially controls nearly every aspect of our physiology, including metabolism and appetite. That creates the possibility that targeting this widespread system could unlock new therapies for these conditions. https://www.sfgate.com/cannabis/article/cannabis-weight-loss-california-study-22255328.php XX A new campaign launched by diaTribe and Genentech aims to empower and educate people about diabetes-related eye disease. Here's what you can do today to protect your eye health. To help address these barriers, diaTribe and Genentech partnered to launch All Eyes on DME, a new campaign that aims to spread awareness and educate people at-risk for or living with diabetes-related eye conditions like DME. Also partnering in the campaign is actor and comedian Damon Wayans, who wanted to share his journey (and, of course, a joke or two) with type 2 diabetes to open up the conversation about what is often a stigmatized or less talked about topic: eye health and diabetes. One of these important conversations happened recently at the All Eyes on DME launch in New York City, where Wayans joined a panel of experts, advocates, and people living with DME to talk about diabetes-related eye disease and how to help prevent it. https://www.alleyesondme.com/dme-in-the-spotlight.html https://diatribe.org/diabetes-complications/all-eyes-dme-new-campaign-spotlights-eye-health-and-diabetes
Dean's Chat is live on location at the American College of Foot and Ankle Surgeons -Annual Scientific Conference in Las Vegas Nevada! Dr. Richey is joined by the ACFAS student leadership; Lily Cohen from Midwestern University, Fareeha Rafa from Temple University, Madeline Adkins from University of Texas Rio Grande Valley and Pierce Burke from Schol College of Podiatric Medicine. Join us as we discuss “all things podiatric medicine and surgery” including what its like to be a part of student leadership in the largest group of Foot and Ankle Surgeons worldwide.At its core, the ACFAS ASC is a large, multi-day conference focused on advancing surgical knowledge, clinical skills, and professional development in foot and ankle surgery. It brings together practicing surgeons, residents, and students from across the country. Listen, as we get the student experience inside the event. The meeting is built around several key components:• Scientific education: Evidence-based lectures, panel discussions, and case reviews covering topics like trauma, deformity correction, sports injuries, and limb salvage. • Research presentation: Surgeons and trainees present original research (posters and podium talks), highlighting new data and evolving techniques. • Hands-on learning: Skills labs and workshops allow attendees to practice surgical techniques and familiarize themselves with new technology. • Networking and mentorship: Opportunities to connect with leaders in the field, residency programs, and peers. • Exhibit hall: Industry partners showcase implants, devices, and surgical innovations. In practical terms, the ASC functions as one of the most important annual touchpoints in podiatric surgery, where new ideas are shared, standards of care are debated, and professional relationships are built. We hope you enjoy!
NASM Master Instructor Roundtable: A Show for Personal Trainers
Welcome to another high-impact episode of the “Master Instructor Roundtable!”In this episode, Wendy Batts and Dr. Marty Miller break down the latest American College of Sports Medicine (ACSM) Position Stand: “Resistance Training Prescription for Muscle Function, Hypertrophy and Physical Performance in Healthy Adults”—the first major update since 2009.
In this episode of Parallax, Dr Ankur Kalra welcomes Dr Eunice Dugan, a graduating interventional and structural heart disease fellow at the Cleveland Clinic, as she prepares to transition into independent practice in Fort Wayne in the summer of 2026. Dr Dugan reflects on how early mentorship shaped her decision to engage with the American College of Cardiology during fellowship, and what professional societies can offer beyond the clinical environment — from expanding skill sets and building lasting networks to driving meaningful change. She shares how her role as a local FIT representative led her to organise a widely attended webinar helping fellows navigate the new interventional cardiology match. The conversation also tackles the attrition challenge that affects many early-career cardiologists in their first three to five years of practice: Dr Dugan, now transitioning into the ACC's Early Career Council, discusses the "fog" of establishing a new career and makes the case for cultivating a specific project during fellowship as a professional anchor through the pressures of a new post, relocation, and family life. She also speaks to her advocacy for women in cardiology, including championing open discussion around family planning and reproductive strategies — topics that remain underaddressed in the field. Questions and comments can be sent to podcast@radcliffe-group.com and may be answered by Ankur in the next episode. Host: @AnkurKalraMD and produced by: @RadcliffeCardio Parallax is Ranked in the Top 100 Health Science Podcasts (#48) by Million Podcasts.
Recorded at the ACOEP's Spring Seminar, this conversation between Drew, Tanner, John, and Andy discusses the topic of staying great at our jobs over the course of an ever changing landscape and other factors over our careers. A great discussion for any EM doc (old and young alike) to listen too. Don't forget we are the official podcast of the American College of Osteopathic Emergency Physicians. Visit acoep.org today to learn more.
(0:00) Intro (1:47) About the podcast sponsor: The American College of Governance Counsel (2:34) Start of interview (4:12) Laurie's origin story (6:19) From Management Consulting (Accenture) to Product Innovation (Visa). "What they all had in common was that I got to start with a blank sheet of paper." (8:52) Toward Venture Capital and Board Governance. From Sun Microsystems to Packet Design to investing. (13:07) How she got interested in board governance. Her first board experience with Interactive Investor (cross-listed in US and UK) (14:27) Joining Playground Global in 2019 (16:16) Tesla's Day-Zero Board (20:15) Zoox and Autonomous Ambition (24:11) Boards Across Company Types: VC-backed companies and family businesses. Example of her time as board member at Bose. (27:57) Lessons from Church and Dwight. The roles of M&A and marketing. (30:37) Her co-authored paper on The Artificially Intelligent Boardroom (Stanford GSB) (35:30) Private Markets and Trillion-Dollar Valuations (40:28) The role of private equity in this environment, and its distinctive board structure. (42:55) Geopolitics and Supply Chains (47:20) Cybersecurity Oversight in the AI Age (50:45) Courage in the Boardroom. “As board members, we have to be courageous enough to ask the right questions at the right time, rather than sit back and hope everything will be okay.” (52:22) Books that have greatly influenced her life: Night Train to Lisbon, by Pascal Mercier (2004) The Immortal Life of Henrietta Lacks, by Rebecca Skloot (2010) Sapiens: A Brief History of Mankind, by Yuval Noah Harari (2011) (54:14) Her mentors: Heidi Roizen Scott McNealy Peggy Johnson (56:49) Quotes that she thinks of often or lives her life by. "It is easy enough to be pleasant, when life flows by like a song, but the man worth while is one who will smile, when everything goes dead wrong." Ella Wheeler Wilcox (57:32) An unusual habit or an absurd thing that she loves. Dancing, after following research from Kelly McGonigal. Hummingbird feeders. (59:39) The living person she most admires: her husband, Ben Lenail. Laurie Yoler is a venture capital investor at Playground Global, former board member at Tesla and Zoox, and a director or advisor to more than 25 boards. She currently serves on the boards of Church & Dwight and the NACD Northern California Chapter. You can follow Evan on social media at:X: @evanepsteinLinkedIn: https://www.linkedin.com/in/epsteinevan/ Substack: https://evanepstein.substack.com/__To support this podcast you can join as a subscriber of the Boardroom Governance Newsletter at https://evanepstein.substack.com/__Music/Soundtrack (found via Free Music Archive): Seeing The Future by Dexter Britain is licensed under a Attribution-Noncommercial-Share Alike 3.0 United States License
Explore family office models, services, and key planning considerations for ultra-high-net-worth families, from single-family offices to MFOs. The American College of Trust and Estate Counsel, ACTEC, is a professional society of peer-elected trust and estate lawyers in the United States and around the globe. This series offers professionals best practice advice, insights, and commentary on subjects that affect the profession and clients. Learn more in this podcast.
Robert Pass is Professor of Pediatrics and Chief of the Division of Pediatric Cardiology at the Icahn School of Medicine at Mount Sinai and Mount Sinai Kravis Children's Hospital. He is Co-Director of the Mount Sinai Kravis Children's Heart Center and Director of Pediatric Electrophysiology at the Mount Sinai Health System. In addition to his exceptional clinical work as an electrophysiologist, he is the host of the very successful medical education podcast Pediheart: Pediatric Cardiology Today.Learning Objective: By the end of this podcast, listeners should be able to discuss an evidence-based and expert-guided approach to the evaluation and management of high-grade atrioventricular block in children.References:PediHeart Podcast with Robert Passhttps://www.youtube.com/@RobertPassPediheart Kusumoto et al. 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. J Am Coll Cardiol. 2019 Aug 20;74(7):932-987.Questions, comments or feedback? Please send us a message at this link (leave email address if you would like us to relpy) Thanks! -Alice & ZacSupport the showHow to support PedsCrit:Please complete our Listener Feedback SurveyPlease rate and review on Spotify and Apple Podcasts!Donations are appreciated @PedsCrit on Venmo , you can also support us by becoming a patron on Patreon. 100% of funds go to supporting the show.Please remember that all content during this episode is intended for educational and entertainment purposes only. It should not be used as medical advice. The views expressed during this episode by hosts and our guests are their own and do not reflect the official position of their institutions. If you have any comments, suggestions, or feedback-you can email us at pedscritpodcast@gmail.com. You can also check out our website at http://www.pedscrit.com. Thank you for listening to this episode of PedsCrit!
In this solo episode of Keeping Abreast, Dr. Jenn Simmons takes on one of the most accepted messages in women's health and dismantles it with decades of evidence. Routine yearly mammography screening does not hold up when you actually read the trials. Dr. Jenn walks through the WISDOM trial, the Cochrane Review, the Canadian Breast Cancer Screening Study, and the brand new 2026 American College of Physicians guidelines to make the case that one-size-fits-all screening is not just outdated, it is causing real harm.She also takes on the estrogen myth that has left millions of women suffering through hot flashes, bone loss, brain fog, and lost quality of life for decades. A 1.8 million woman study and the Women's Health Initiative say estrogen is not the villain. The real culprit may be something millions of women are still being prescribed today.If you have ever been told to just get your mammogram every year without a single conversation about the risks or what the data actually shows, this is the episode you have been waiting for.What You'll LearnWhat the 2026 American College of Physicians guidelines say about annual mammography and why radiology groups do not want you to hear itWhat the WISDOM trial found when women received fewer mammograms and why the results challenge everything we have been toldWhat the Cochrane Review and Canadian Breast Cancer Screening Study concluded after studying hundreds of thousands of women over decadesWhy up to 50 percent of screen-detected cancers may have never grown, spread, or threatened a woman's life and what that means for how we treat themWhy estrogen alone has never been shown to cause breast cancer and what the data actually implicates insteadThe difference between synthetic progestins and bioidentical progesterone and why that distinction could change every conversation about hormones and breast cancerWhat BRCA mutation carriers need to know about hormone replacement therapy after risk-reducing surgeryWhat smarter, safer, individualized breast cancer screening actually looks likeEpisode Timeline00:00 Introduction01:08 This Is an Informed Consent Episode04:00 The WISDOM Trial and the End of One-Size-Fits-All Screening08:30 Fewer Mammograms, No More Advanced Cancers11:41 Why Adding MRI Led to More Biopsies and Zero Benefit15:00 The Only Endpoint That Actually Matters17:30 What the Cochrane Review Actually Found19:30 The Number Every Woman Deserves to Hear23:00 The Canadian Breast Cancer Screening Study27:00 What Overdiagnosis Really Means31:00 The 2026 American College of Physicians Guidelines36:03 The Estrogen Myth41:00 The Women's Health Initiative Unpacked49:00 Birth Control, Progestins, and Breast Cancer Risk53:00 Progestins Are Not Progesterone57:00 BRCA Mutation Carriers and HRT: What the 2026 JAMA Data Shows01:03:00 The Future of Breast Cancer ScreeningStudies Mentioned in This EpisodeThe WISDOM Trial — JAMAThe Cochrane Mammography Review — CochraneThe Canadian National Breast Screening Study: 25 Year Follow-up — BMJ 2014ACP Breast Cancer Screening Guidance Statement — Annals of Internal Medicine 2026Cracks in the Estrogen Carcinogenesis of Breast Cancer — Journal of Clinical Oncology 2026Hormonal Contraception and Breast Cancer Risk — NEJM 2017Menopausal Hormone Therapy and Breast Cancer: Women's Health Initiative — JAMA Oncology 2020HRT After Oophorectomy and Breast Cancer Risk in BRCA Carriers — JAMA Network Open 2026To talk to a member of Dr. Jenn's team and learn more about working privately with Dr. Jenn visit: https://calendly.com/stephanie-1031/clarity-callTo get your copy of Dr. Jenn's book, The Smart Woman's Guide to Breast Cancer, visit: https://tinyurl.com/SmartWomansBreastCancerGuideTo purchase the auria breast cancer screening test go here https://auria.care/ and use the code DRJENN20 for 20% Off.Connect with Dr. Jenn:Website: https://www.jennsimmonsmd.com/Facebook: https://www.facebook.com/DrJennSimmonsInstagram: https://www.instagram.com/drjennsimmons/YouTube: https://www.youtube.com/@dr.jennsimmons
Lifestyle Medicine & Breast Cancer: Prevention, Treatment Support & Recovery What actually impacts cancer risk—and what helps you get through it? This episode blends expert insight and lived experience to reveal how lifestyle medicine supports prevention, treatment, and healing. In this episode of Her Health Compass, we explore what it truly means to heal through the lenses of resilience, grief, and lifestyle medicine. Yonni and Heather are joined by Dr. Amy Comander, a breast cancer specialist trained in lifestyle medicine, and Britt Aronson, who shares her powerful firsthand experience navigating cancer alongside profound personal loss. Together, they unpack how nutrition, movement, sleep, stress, and mindset can influence not only cancer prevention, but also treatment outcomes and recovery. This conversation bridges science and story—offering both evidence-based insight and lived experience for anyone seeking to better understand their body, their health, and their capacity to heal. Amy Comander, MD, DipABLM, FACLM, MSCP is a breast oncologist and Medical Director of the Mass General Brigham Cancer Institute in Waltham, Director of the Lifestyle Medicine Program at the Mass General Brigham Cancer Institute, and an instructor in medicine at Harvard Medical School. Dr. Comander developed a passion for understanding the biological basis of behavior, and she studied neurobiology and psychology as part of the multidisciplinary Mind, Brain, and Behavior Initiative at Harvard University. She then received her Doctor of Medicine from the Yale University School of Medicine. She completed her internal medicine residency training and Hematology-Oncology fellowship training at Beth Israel Deaconess Medical Center and Harvard Medical School. She is board-certified in internal medicine, hematology, medical oncology, and Lifestyle Medicine. As a breast oncologist, Dr. Comander has witnessed the struggles her patients face during and following completion of primary cancer treatment, and is passionate about improving the overall health and well-being of breast cancer survivors through lifestyle interventions. In collaboration with Dr. Frates, she launched the PAVING the Path to Wellness Program lifestyle medicine program for breast cancer survivors. She trains other colleagues to run PAVING groups, so that this transformational experience can be offered to a larger group of cancer survivors. She has co-authored PAVING Your Path Through Breast Cancer and Beyond, PAVING the Path to Wellness Manual and Workbook, and PAVING a Path Through Menopause and Beyond. Dr. Comander practices what she preaches, having run marathons, including 12 consecutive Boston Marathons to date, with the goal to improve the lives of those with a diagnosis of cancer. Dr. Comander was honored to serve as the first oncologist on the Board of Directors of the American College of Lifestyle Medicine. She is proud to serve as Vice President on the Board of the PAVING the Path to Wellness non-profit organization. She also serves on the Board of the Ellie Fund, a non-profit that provides services and support to women diagnosed with breast cancer in Massachusetts. She is a medical advisor to the non-profit organizations, SurvivingBreastCancer.org and the Tigerlily Foundation. She has served as a medical advisor to Oneinforty, a non-profit organization dedicated to educating people of Ashkenazi Jewish heritage about the one-in-forty chance of having inherited a BRCA mutation. Britt Aaronson is a freelance writer and editor based in Los Angeles, where she has lived since 1993. She finds great joy in being a mother to Rayce and Eisley. In her free time, she enjoys yoga, hiking, traveling, and supporting nonprofits including the National Brain Tumor Society, the Hidden Hills Theater Committee, and the Fondle Project. In February 2020, she was diagnosed with Grade 2–3 DCIS breast cancer. Britt underwent seven surgeries—including a double mastectomy, reconstruction, and capsulectomies—and is grateful to now be cancer-free. Deeply appreciative of the technology that led to her diagnosis, she is dedicated to raising awareness and helping redefine conversations around breast health, survivorship, and healing. Find Yonni & Heather here https://www.herhealthcompass.com/
Text Dr. Lenz any feedback or questions Beyond the Pain Scale: Using WPI/SSS and FIQR to Measure Fibromyalgia Severity and Treatment ProgressThe script explains that fibromyalgia care often relies too heavily on a 1–10 pain scale, overlooking fatigue, unrefreshed sleep, brain fog, and daily function, which leaves patients feeling unheard and clinicians without clear data. It describes how the American College of Rheumatology shifted from the 1990 tender point exam to revised criteria (2010, refined in 2011 and 2016) using two quick questionnaires: the Fibromyalgia Survey Criteria—Widespread Pain Index (19 pain regions) plus Symptom Severity Score (fatigue, unrefreshed sleep, cognitive symptoms, plus headaches/abdominal pain/depression), combined as the PSD—and the Revised Fibromyalgia Impact Questionnaire (FIQR), a 21-item measure of function, overall impact, and symptoms scored 0–100. Examples show how these tools provide baselines, track change, guide treatment adjustments, and capture clinically meaningful improvement beyond pain alone.00:00 Beyond the Pain Scale01:04 Why Fibro Gets Missed03:36 Old Criteria to New Tools04:30 Two Key Questionnaires05:45 Widespread Pain Index07:49 Symptom Severity Score09:35 Diagnosis and Tracking Baseline10:50 Advocating at Appointments11:22 FIQR Daily Function12:59 FIQR Impact and Symptoms15:51 Meaningful Improvement Benchmarks16:16 Using Both Tools Together19:05 Tracking Life Factors Over Time20:35 Wrap Up and Next StepsClick here for the YouTube Channel Support the showWhen I started this podcast and YouTube Channel—and the book that came before it—I had my patients in mind. Office visits are short, but understanding complex, often misunderstood conditions like fibromyalgia takes time. That's why I created this space: to offer education, validation, and hope. If you've been told fibromyalgia “isn't real” or that it's “all in your head,” know this—I see you. I believe you. This podcast aims to affirm your experience and explain the science behind it. Whether you live with fibromyalgia, care for someone who does, or are a healthcare professional looking to better support patients, you'll find trusted, evidence-based insights here, drawn from my 29+ years as an MD.Please remember to talk with your doctor about your symptoms and care. This content doesn't replace per...
In this series, we are exploring the common and not-so-common specialties in medicine. Nuclear medicine sits at the crossroads of imaging and molecular science, revealing how disease behaves at a cellular level rather than just how it looks. In this episode, we explore how this often-overlooked specialty is shaping diagnosis, guiding therapy, and redefining the future of precision medicine.Dr. Erica Major is the Assistant Chief of Nuclear Medicine and Site Director of Radiology and Nuclear Medicine Education at Edward Hines VA, where she oversees medical student and resident training. She holds multiple leadership positions in the American College of Nuclear Medicine and the Society of Nuclear Medicine and Molecular Imaging, and is a past member of the ACGME Residency Review Committee. Her primary interest is advancing the field of theranostics, which combines nuclear oncology with personalized cancer therapy. You can contact Dr. Major at erica.major@va.gov To learn more about nuclear medicine, check out these sources:https://acnmonline.org/https://snmmi.org/ Episode produced by: Rasa ValiaugaEpisode recording date: 4/2/26www.medicuspodcast.com | medicuspodcast@gmail.com | Donate: http://bit.ly/MedicusDonate
As I have said many times before, some podcast ideas come from REAL clinic encounters. In this episode, Dr Hanna V, our dedicated PGY1 on our call team, and I will answer TWO real questions which arose just today on morning rounds, on our service: 1. Does NORMOTENSIVE HELLP still need Mag Sulfate? And 2. Does an indwelling foley s/p iatrogenic bladder injury at CS require prophylactic antibiotic coverage for urinary infection? Yep: It's a BOGO sale on today's podcast- Buy ONE GET ONE! Listen in for details.1. Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222.Obstetrics and Gynecology. 2020. Committee on Practice Bulletins—ObstetricsGuideline2. Woudstra DM, Chandra S, Hofmeyr GJ, Dowswell T.SR. Corticosteroids for HELLP (Hemolysis, Elevated Liver Enzymes, Low Platelets) Syndrome in Pregnancy.The Cochrane Database of Systematic Reviews. 2010. 3. Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA.Liver Disease in Pregnancy. Lancet. 2010. Review4. Rimaitis K, Grauslyte L, Zavackiene A, et al.Observational. Diagnosis of HELLP Syndrome: A 10-Year Survey in a Perinatology Centre. International Journal of Environmental Research and Public Health. 20195. Reau N, Munoz SJ, Schiano T.Guideline Liver Disease During Pregnancy.The American Journal of Gastroenterology. 2022. 6. ACG Clinical Guideline: Liver Disease and Pregnancy.The American Journal of Gastroenterology. 2016. Tran TT, Ahn J, Reau NS.7. ACOG Practice Bulletin No. 195: Prevention of Infection After Gynecologic Procedures. Obstetrics and Gynecology. 2018. Committee on Practice Bulletins—Gynecology Guideline8. Niels Johnsen, Hunter Wessells, Krystal Archer-Arroyo, et al. Best Practices Guidelines Management of Gentiunrinary Injuries.American College of Surgeons (2025). 20259. Fletke KJ, Jeong DH, Herrera AV . Urinary Catheter Management. American Family Physician. 2024..
Let's talk about fear-free feline anesthesia! Feline anesthesia has changed dramatically, and so has our understanding of pain in cats. Our next Purr Podcast guest, Dr. Tamara Grubb, is a Diplomate of the American College of Veterinary Anesthesia and Analgesia and an internationally recognized expert in pain management. She shared the biggest mistakes that veterinarians make in feline anesthesia!Thanks for tuning in to the Purr Podcast with Dr. Susan and Dr. Jolle!If you enjoyed today's episode, don't forget to subscribe, rate, and leave us a review—it really helps other cat lovers and vet nerds find the show. Follow us on social media for behind-the-scenes stories, cat trivia, and the occasional bad pun. And remember: every day is better with cats, curiosity, and maybe just a little purring in the background. Until next time—stay curious, stay kind, and give your cats an extra chin scratch from us. The Purr Podcast – where feline medicine meets feline fun.
In this episode of Dean's Chat, Drs. Jeffrey Jensen and Johanna Richey welcome Dr. Ron Raducanu for a wide-ranging conversation about podiatric medicine, mentorship, mission work, online discourse, and building a meaningful career in the profession. Originally from Montreal, Canada, Dr. Raducanu shares the unexpected story of how he discovered podiatry after literally colliding with a podiatrist on his way to class during his undergraduate studies at Concordia University. That encounter ultimately led him to the Temple University School of Podiatric Medicine and a lifelong commitment to podiatric education, surgery, and service.The discussion dives into the unique challenges Canadian students face when pursuing podiatric training in the United States, including visa hurdles, residency limitations, and immigration logistics. Dr. Raducanu reflects candidly on his own journey navigating student visas, residency sponsorships, and eventual U.S. citizenship while encouraging transparency and mentorship for future international students entering the profession.Dr. Raducanu also discusses his current private practice model in southern New Jersey, where a collaborative culture allows physicians to focus on their individual strengths while providing comprehensive patient care. The conversation highlights the importance of collegiality, specialization, and professional respect within podiatry, emphasizing how strong teamwork benefits both physicians and patients alike.The episode also explores Dr. Raducanu's extensive commitment to academics and organized medicine, including his decade-long leadership role with the American College of Foot and Ankle Pediatrics. He reflects on building the organization from the ground up and the lessons learned from leading a national nonprofit largely through volunteer effort and determination.One of the most compelling portions of the interview centers on Dr. Raducanu's mission work in Nigeria, where he has helped provide foot and ankle care in underserved communities while working to develop podiatric education pathways within the country's medical system. He shares stories of cultural immersion, resource-limited surgical environments, and his vision for establishing long-term lower extremity care and training programs in West Africa.Finally, the conversation shifts to social media and Dr. Raducanu's role as a moderator on Reddit's podiatry forum, which has grown to over one million views annually. The group discusses the challenges of anonymous online discourse, the need for professionalism in digital spaces, and the importance of creating constructive forums for honest conversations about podiatric medicine. Throughout the episode, listeners are reminded of the power of mentorship, service, collaboration, and authentic dialogue in advancing the profession.
This week on The Hamilton Review Podcast, we're pleased to welcome Dr. Akansha Ganju. Dr. Akansha Ganju is a board-certified allergist and immunologist with a passion for delivering comprehensive, patient-centered care for both adults and children with allergic conditions. She leads Latitude's Los Angeles clinic in West LA, providing specialized life-changing care for food allergy patients of all ages. In this must listen episode, Dr. Ganju discusses food allergies in children and the steps an immunologist can take to diagnose and create a personalized treatment plan for the child and their family. Prior to joining the Latitude team, Dr. Ganju was the Medical Director at Nectar Allergy Center where she played a pivotal role in developing and expanding the startup's inaugural clinic for innovative allergy treatment. Dr. Ganju graduated from an accelerated, combined baccalaureate-M.D. program and received her medical degree from Northeast Ohio Medical University. She is board-certified in internal medicine and completed her residency at Riverside Methodist Hospital in Columbus, Ohio. She went on to complete her allergy and immunology fellowship at UCLA and the VA Greater Los Angeles Healthcare System. Dr. Ganju has authored numerous publications in peer-reviewed journals, conducted both basic science and clinical research, and often presents at healthcare conferences. She is a member of the American Academy of Allergy, Asthma & Immunology (AAAAI) and American College of Allergy, Asthma, and Immunology (ACAAI). How to contact Dr. Akansha Ganju: Dr. Akansha Ganju on Instagram Latitude Food Allergy Care Latitude Food Allergy Care on Instagram Latitude Food Allergy Care on Facebook How to contact Dr. Bob: Dr. Bob on YouTube: https://www.youtube.com/channel/UChztMVtPCLJkiXvv7H5tpDQ Dr. Bob on Instagram: https://www.instagram.com/drroberthamilton/ Dr. Bob on Facebook: https://www.facebook.com/bob.hamilton.1656 Dr. Bob's Seven Secrets Of The Newborn website: https://7secretsofthenewborn.com/ Dr. Bob's website: https://roberthamiltonmd.com/ Pacific Ocean Pediatrics: http://www.pacificoceanpediatrics.com/
Pain in cats is notoriously easy to miss and dangerously easy to undertreat, and in this episode of the Purr Podcast, Dr. Susan and Dr. Jolle sit down with Dr. Tamar Grubb to unpack why. A diplomate of the American College of Veterinary Anesthesia and Analgesia with a research focus on multimodal pain management, Dr. Grubb brings both the science and the clinical wisdom to a topic that touches every cat owner and every veterinarian who has ever wondered whether their feline patient is truly comfortable. From the subtleties of recognizing pain in a species that evolved to hide it, to the latest thinking on anesthetic protocols tailored to the unique feline physiology, this conversation is as practical as it is eye-opening. Whether you share your home with a cat or care for them professionally, this is one episode you will not want to miss.
In this episode, Ben and Giacomo are joined by Dr. Michael Greger to discuss one of the most debated topics in nutrition and fitness: protein intake. The conversation covers how much protein we actually need, the potential longevity tradeoffs of excessive protein consumption, and why plant protein may offer unique advantages compared to animal protein.Dr. Greger explains the role of methionine restriction, IGF-1, and mTOR in aging, while also emphasizing the importance of resistance training and muscle mass for long-term health. The group discusses fall prevention, balance training, sarcopenia, insulin sensitivity, and the challenges of communicating science in today's attention economy.The episode wraps up with practical nutrition advice, thoughts on protein powders versus whole foods, and Dr. Greger's enthusiasm for broccoli sprouts and sulforaphane-rich foods.Dr. Greger's Bio: Dr. Michael Greger is a physician, internationally recognized nutrition speaker, and founding Fellow of the American College of Lifestyle Medicine. He runs the nonprofit NutritionFacts.org, which provides free evidence-based nutrition videos and articles. A graduate of Cornell University and Tufts University School of Medicine, Dr. Greger has lectured at the World Bank, testified before Congress, and served as an expert witness in Oprah Winfrey's “meat defamation” trial. He is the bestselling author of How Not to Die, How Not to Diet, and How Not to Age. All proceeds from his books and speaking engagements are donated to charity.
You passed the NBHWC exam — congratulations! Now what? In this episode of The Coaching Lab, Dr. Cooper and Leigh deliver the post-certification roadmap every new National Board Certified Health & Wellness Coach (NBC-HWC) needs. Whether you're aiming for a salaried role at a hospital, corporate wellness program, or insurance company, or you're ready to launch your own coaching practice, this episode walks you through every step.What you'll learn:How to leverage your NBHWC credential on LinkedIn, your resume, and professional bios to signal credibility to employersWhich professional associations are worth joining (National Wellness Alliance, American College of Lifestyle Medicine, and more)The real pros and cons of employment vs. contractor work vs. entrepreneurship — plus hybrid models that let you do bothWhere health and wellness coaches are actually getting hired right now (hospitals, corporate wellness, health insurance, gyms, EAPs) and what salary to expectHow to start your own coaching practice: business structure (LLC vs. sole proprietor), setting your rates, landing your first clients, and the tech stack you need (scheduling, payments, video, notes)Marketing that works for health coaches: niching down, building an online presence without burnout, content creation, in-person networking, referral partnerships, and Google Business ProfileScope of practice, liability insurance, client agreements, intake forms, and HIPAA basics for clinical settingsRecertification planning (36 CEs every 3 years), advanced credentials, mentorship, and peer supportMindset essentials: navigating imposter syndrome, setting boundaries early, and building a sustainable practice instead of burning out in year oneWhether you're a brand-new health coach, a wellness professional adding NBHWC to your credentials, or an aspiring coach planning your next move, this episode is the practical, no-fluff guide to turning your certification into a thriving career. Info re earning your health & wellness coaching certification, annual Rocky Mountain Coaching Retreat & Symposium & more via https://www.catalystcoachinginstitute.com/ Best-in-class coaching for Employers, EAPs & wellness providers https://catalystcoaching360.com/Tap into the home of the (freely available) Not Done Yet! articles on unlocking life's 2nd half here.YouTube Coaching Channel https://www.youtube.com/c/CoachingChannelContact us: Results@CatalystCoaching360.comTwitter: @Catalyst2ThriveWebsite: CatalystCoaching360.comIf you are a current or future health & wellness coach, please check out our Health & Wellness Coaching Community on Facebook: https://www.facebook.com/groups/278207545599218. This is a wonderful group if you are looking for encouragement, ideas, resources and more.
Listen as Andy is joined by guest Brian Acunto, Chris Colbert, and Peter Alamia to discuss ways to combat the ever-changing nature of EM. Don't forget we are the official podcast of the American College of Osteopathic Emergency Physicians. Visit acoep.org today to learn more.
(0:00) Intro (1:34) About the podcast sponsor: The American College of Governance Counsel (2:21) Start of interview (3:20) Marie's origin story (5:19) Career Path in Law and Governance. Her time at HP and Agilent Technologies. (7:50) Transition to eBay (9:57) Shareholder Activism and eBay's Story *CNBC clip with Ryan Cohen (14:42) Governance Roles and Board Memberships (16:50) Her teaching positions on the role of the General Counsel (18:57) Chair and Director Succession (23:37) On separating Chair and CEO roles (25:44) Governance in Private Companies (30:40) The Impact of AI on Governance. She thinks of it in three buckets: 1) Customer/revenue opportunity; 2) from an enterprise wide standpoint; and 3) AI risks (34:36) Questions board members should ask management regarding AI opportunities and challenges (38:09) Energy Sector and AI *Marie serves on the board of Portland General Electric (43:10) Geopolitical Challenges in Business *reference to Meta-Manus China breakup (45:24) Building Trust in the Boardroom (48:30) Books that have greatly influenced her life: The Book of Alchemy, by Suleika Jaouad (2025) Phoenix in a Jade Bowl, by Bonnie Bongwan Cho Oh (her mother) (2013) Atomic Habits, by James Clear (2018) (50:32) Her mentors (52:38) Quotes that she thinks of often or lives her life by. (54:00) An unusual habit or an absurd thing that she loves. (56:00) The living person she most admires: Lisa Su. Marie Oh Huber has over 30 years of experience of strategic business, legal, regulatory and public policy experience in large global public technology companies, including eBay, Agilent Technologies, and HP. She currently serves on the board of Portland General Electric You can follow Evan on social media at:X: @evanepsteinLinkedIn: https://www.linkedin.com/in/epsteinevan/ Substack: https://evanepstein.substack.com/__To support this podcast you can join as a subscriber of the Boardroom Governance Newsletter at https://evanepstein.substack.com/__Music/Soundtrack (found via Free Music Archive): Seeing The Future by Dexter Britain is licensed under a Attribution-Noncommercial-Share Alike 3.0 United States License
We can measure more about our health than ever before. Wearables track everything from heart rhythms to glucose trends, and AI can now identify patterns clinicians might miss. But more data does not automatically mean better health outcomes.In this episode, cardiologist and digital health expert Dr. Ami Bhatt joins Mike Haney to explore why medicine still struggles with prevention, how continuous health data can help patients take more agency, and where AI may actually improve care—not by replacing doctors, but by helping clinicians navigate the right information at the right time.They discuss the promise and pitfalls of wearables, the challenge of turning constant streams of health information into useful action, and why the future of medicine may depend on what Dr. Bhatt calls “collaborative intelligence”: humans and AI working together to make better decisions earlier.About the guest: Dr. Ami Bhatt is the chief innovation officer (CIO) at the American College of Cardiology and the Chair of the FDA Digital Health Advisory Committee. She received her undergraduate degree at Harvard University and her Doctor of Medicine at Yale University School of Medicine, and was the Director of Outpatient Cardiology, TeleCardiology, and Adult Congenital Heart Disease at the Massachusetts General Hospital.Sign Up to Get Your Free Ultimate Guide to Glucose: https://levels.link/wnl
Dr. Courtney Conley holds a Doctorate in Chiropractic Medicine as well as two bachelor's degrees in Kinesiology and Human Biology. The founder and creator of Gait Happens, she has worked with professional athletic teams including the Phoenix Suns, New York Yankees, Cleveland Browns, New York Giants, San Francisco 49ers, and Minnesota Vikings. Dr. Conley is Head of Patient Care at Total Health Solutions and Total Health Performance, premier healthcare destinations renowned for their comprehensive and science-based approach to patient care. Dr. Milica McDowell holds two Bachelor of Science degrees (Exercise Physiology and Health Promotion, (Montana State University), a master's degree (Physical Therapy, University of Colorado Health Sciences Center), and a Doctorate degree (Physical Therapy, Idaho State University). She served as a university faculty member in Human Performance for nearly a decade, has developed numerous medical education curricula and has been an invited speaker on many national stages, including the American Physical Therapy Association and American College of Sports Medicine's conventions. Today on the show we discuss: why the 10,000 step rule is a myth rooted in marketing not science, how walking is a biological necessity that impacts your metabolism brain and mental health, why small “micro walks” can dramatically improve mood confidence and long-term consistency, the truth about fat loss and why walking works when you stack it with better sleep breathing and nutrition, how modern shoes are weakening your feet and what to do instead, and how to build a simple walking routine that actually improves longevity reduces depression and lowers your risk of disease and much more. Learn more about your ad choices. Visit megaphone.fm/adchoices
© 2020-2026 Ivy Podcast Discovery LLC
